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SELEX technology has been a powerful tool to evolve aptamers that can bind 
tightly and specifically to a target. Aptamers are nucleic acids with the propensity to 
assume three-dimensional structures facilitating specific binding interactions with high 
affinity to the target. Principally, aptamers are selected from a large pool of random 
sequences by an iterative in vitro method. The main advantages of this technology are that 
aptamers can be produced in a large scale by a controlled combinatorial chemistry method, 
easily derivatized regioselectively for detection using dyes, and they are stable for long 
periods at room temperature when dry. Therefore, single-stranded DNA aptamers are 
robust binding agents with good shelf-life and easy production and do not require a 
biological host. One of the most difficult challenges of this technology is that there is no 
standardized SELEX protocol applicable for all types of target, which in this dissertation 
includes damaged bases and nucleosides.  
The first work presented here focuses on identification of products that formed from 
the reaction of Ni(II)-mediated sulfate radical oxidation of the guanine base. It was 
observed that a Ni(II)-macrocyclic square-planar complex, NiCR, in the presence of  
KHSO5 can generate a specific hydantoin lesion called 2-iminohydantoin (2-Ih) in both 
nucleoside and single-stranded DNA, along with the other well-known guanine oxidation 
products. The initial goal was to optimize the 2-Ih formation followed by isolation of this 
iv 
 
lesion. Fine tuning the oxidation conditions with respect to the concentration of KHSO5 
added in certain time intervals made it possible to generate 2-Ih exclusively.  
Secondly, SELEX technology was used to select aptamers for the oxidized 
damaged bases and nucleosides as an approach toward detection of these targets. The 
structure-switching or capture SELEX technique was used as a successful method to 
generate DNA aptamers for these targets that are difficult to immobilize or derivatize and 
purify in the large quantities needed to perform typical SELEX procedures. The targets 
include the most common oxidation products that are generated as a part of the most 
important cellular repair pathways, base excision and nuclear excision repair. These 
products are the damaged nucleobases and 2’-deoxynucleosides of 8-oxo-7,8-
dihydroguanine (8-oxo-G) and spiroiminodihydantoin (Sp). This is the first time that 
aptamers are reported for the damaged diastereomeric lesions, dSp.  
Lastly, sensors have been developed by truncating these aptamers as a part of post-
SELEX modification and the binding affinities for these sensors toward the damaged 
lesions were determined. The future direction aims toward testing these aptamers by using 
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Mitochondrial (mt) and nuclear (nt) DNA oxidation 
An imbalance between the generation of reactive oxygen species (ROS) and the 
activity of repair enzymes or detoxification processes can result in the deregulation of 
homeostasis generating oxidative stress in a cell (Figure 1.1). ROS are the byproducts of 
cellular metabolic cycles that consist of different types of oxygen ions and peroxides.1-3 
Besides ROS, reactive nitrogen species (RNS) also play an important role in the process of 
energy production, lipid peroxidation, oxygenation, nitration, and deamination of DNA.4, 5 
There are ramifications to excessive production of either of these reactive species in a cell 
leading to various pathological conditions. These free radicals can result in destruction of 
tissue leading to tumor progression. It also influences signal transduction cascade in a cell 
by activating transcription factors that have cellular response to stress, or initiate damage 
to DNA, lipids, and proteins that can increase the risk of mutations.6, 7 Exposure to 
exogenous sources such as ionizing radiation, therapeutic drug, occupational, or habitual 
exposure to oxidizing agents results in the generation of free radicals and disturbs the 
normal cellular metabolism. The effect of these free radicals in both mt and nt DNA include 































Figure 1.1.  A balance between the levels of free radicals and antioxidants is important for 
normal functioning of a cell. Oxidative stress in a cell due to an imbalance in the production 
of these results in an imbalance in homeostasis and a diseased state. This figure has been 





The mtDNA is circular and encodes two ribosomal RNAs, 22 transfer RNAs, and 
13 proteins that are subunits of the oxidative phosphorylation system. Mitochondrial 
respiration is an endogenous source of ROS that comprises hydroxyl radical (•OH), 
superoxide (O2•−), and hydrogen peroxide (H2O2).9 During high metabolic demand, it is 
noted that ~1% of electrons leak from the electron transport system (ETS) converting 
molecular oxygen (O2) to O2•−, and a significant amount of superoxide is also liberated by 
the ETS.10  An accurate functioning of the mitochondria is important to avoid imbalance 
in generation of ROS. Mitochondria function as an alarm system that accumulates 
biomarkers of stress indicating diseased state. The proximity of mtDNA to oxidative 
phosphorylation system accounts for higher mutational frequency in mtDNA as compared 
to ntDNA.11 Deletions to the mtDNA result in Kearns-Sayer syndrome (KSS) and 
myopathies,12, 13 while point mutations in mtDNA have been found in Leber’s hereditary 
optic neuropathy (LHON).14 More than 200 pathogenic mtDNA mutations have been 
identified.15 These mutations have also been correlated to aging and neurodegenerative 
diseases.16-19 Although mitochondrial disorders do not follow Mendelian inheritance like 
other genetic disorders, they are significant as they are exclusively inherited maternally. 
Oxidation of ntDNA from both endogenous and exogenous sources results in 
disruption of normal cellular metabolism.20-22 Oxidation of the four canonical DNA bases 
with various ROS affect cellular proliferation, damage to repair enzymes, and polymerases 
and result in enzymatic infidelity during replication. Also, binding of the end products of 
lipid peroxidation to DNA results in mutagenesis.23 Chronic inflammation, exposure to 
radiation, and cigarette smoke are all known to cause DNA oxidation by free radicals. The 




of purines or C-4 and C-5 of pyrimidines. DNA oxidation by highly reactive radicals yields 
various pyrimidine and purine adducts; some of these are thymine glycol (Tg), 5-
hydoxycytosine (5-hC), 2,6-diamino-4-hydroxy-5-formamidopyrimidine (Fapy-G or 
Fapy-A), 8-hydroxy adenine, and numerous other oxidation products.24  
 
Oxidation of 2’-deoxyguanosine 
The most vulnerable purine to oxidation is 2’-deoxyguanosine (dG) because of its 
low redox potential with E° of 1.29 V vs. NHE at pH 7 (Figure 1.2).25 In Chapter 2, we 
discuss the oxidation of dG using the nickel-mediated square planar complex, NiCR and 
KHSO5 resulting in exclusive formation of a relatively new oxidation product 2-
iminohydantoin (2-Ih) that is a lesion.26 dG reacts by one-electron oxidation to form a 
guanine radical cation (dG•+) that can form a plethora of oxidation products including 8-
oxo-7,8-dihydro-2’-deoxyguanosine (8-oxo-dG).27, 28 8-oxo-dG is formed by hydration 
followed by one-electron oxidation of the guanine radical cation. The chemistry of dOG 
has been of great significance as it is the most common oxidative lesion studied. It is an 
important biomarker to monitor oxidative stress in a cell that reaches levels of 0.1- 4.0 per 
106 dGs in the ntDNA.29, 30 If left unrepaired, it can result in dG to T transversion 
mutations.31 Increased levels of dOG have been reported in the early stages of patients with 
Alzheimer’s disease in both mt and ntDNA.32 
8-Oxo-dG is further susceptible to oxidation because of its lower redox potential of 
0.7 V vs. NHE at pH 7 .33 8-Oxo-dG can undergo further two-electron oxidation to form 
the lesions spiroiminodihydantoin-2’-deoxyribonucleoside (dSp) and 5-














Figure 1.2. The redox potential of the four nucleosides at pH 7 vs. NHE. The redox 







































products is both pH and sequence context dependent.34, 35, 37, 38 dGh is a major oxidation 
product in duplexes or in reactions at lower pH (<5.8) whereas in nucleosides and G-
quadruplex, dSp is the major oxidation product, as it is at high pH (>5.8) (Scheme 1.1).37, 
39-41 These hydantoin lesions have also been observed as oxidation products of dG or 8-
oxo-dG with various radicals such as •OH, CO3•−, 1O2 and high valent transition-metal 
species.26, 34, 35, 37, 40, 42 
dSp was first detected in Escherichia coli,43 whereas both dSp and dGh have been 
quantified in mouse model of inflammation leading to colon cancer.44 These lesions result 
in G to C and G to T transversion mutations if left unrepaired in a cell and are 100% 
mutagenic.45-47 The hydantoin lesions exist as two diastereomers that can be separated and 
purified by HPLC.48 Recently, the R and S absolute configurations for the dSp 
diastereomers were assigned using enzymatic, chemical, spectroscopic, and computational 
methods in the Burrows laboratory.49  
 
DNA repair to prevent lesion persistence  
Measurement of these oxidation products is the most common method of assessing 
oxidative stress. It has been suggested that cell death is a potential source of 8-oxo-dG or 
8-oxo-G in urine excretion. Some reports suggest an increase in urine excretion of 8-oxo-
dG because of exposure to radiotherapy or chemotherapy.50-52 The presence of oxidation 
products in extracellular fluids alludes to the enzyme activity involved in repair pathways 
or oxidation of the nucleoside pool. The conservation of genetic information despite the 
presence of damaged bases has propelled scientists to discover DNA damage-specific 


















Scheme 1.1. The two-electron oxidation of dG to form 8-oxo-dG, a biomarker of oxidative 
stress. 8-oxo-dG further oxidizes to hydantoin lesions, dSp and dGh based on pH and 










(BER) that confirms the discovery and use of specific glycosylases that cleave the damaged 
base from the DNA. The role of nucleotide excision repair (NER) is more complex and 
entails removal of lesion-containing longer DNA strands.  
BER is a highly conserved repair pathway in both prokaryotes and eukaryotes and 
results in removal of a majority of damaged bases including oxidized, depurinated, 
deaminated, alkylated bases, and strand breaks in DNA.53, 54 The BER pathway has been 
studied in detail in chromatin, and in telomeres, and it also plays an important role in gene 
regulation and posttranslational modifications. Since the discovery of the first DNA 
glycosylase enzyme by Lindahl, uracil-DNA glycosylases (UDG) that removes uracil from 
DNA, BER is a significant repair pathway studied.55  Among the four steps in BER (Figure 
1.3), the first step involves search for the damaged base or lesion in DNA by the DNA 
glycosylases.56, 57 So far, several DNA glycosylases have been discovered that remove 
oxidative lesions, and most are bifunctional (except NEIL3), meaning they not only cleave 
the damaged base, but also cleave the DNA backbone leaving an α,β-unsaturated aldehyde 
or a phosphate at the 3’-end of the nick. The sugar is removed by phosphodiesterase activity 
of an apurinic endonuclease (APE1) and the phosphate group added by polynucleotide 
kinase (PNK) that adds 3’-phosphate. DNA polymerase β (Pol β) also has lyase activity 
that can beta remove the remaining uncleaved sugar attached to the 5’-phosphate. After the 
gap is filled using pol β, it is sealed by a DNA ligase. 
There are structural and functional homologs of DNA glycosylases that repair 
oxidative base damage in both bacteria and humans.58, 59 We will mainly focus on the 
enzymes in BER associated with the removal of 8-oxo-G and Sp diastereomers. Oxidation 



































Figure 1.3. A representation of BER pathway involved in the identification and excision 
of damaged bases. The different color coded globules on the dsDNA indicate different 






oxo-G in the syn confirmation mimics T and pairs with A(anti), whereas the 8-oxo-G(anti) 
forms a stable bp with C(anti). The crystal structure of DNA polymerase I fragment (BF) 
from B. stearothermophilus indicates that a 8-oxo-G(syn)•A(anti) bp is inaccurately 
bypassed as it mimics a normal bp, whereas 8-oxo-G(anti)•C(anti) disrupts the template 
and polymerase during replication.60 The glycosylases Fpg, MutY, and MutT in E. coli61 
and MUTYH, OGG1, and MTH1 in humans62 constitute the 8-oxo-G repair pathway. 
Hydrolysis and removal of 8-oxo-G occurs by MutT (or MTH1), that prevents 
incorporation of damage by DNA polymerase. MutM (or OGG1) glycosylases excise 8-
oxo-G from 8-oxo-G•C bp whereas Fpg (or MUTY) intercepts 8oxo-G•A bp and removes 
A. Structural studies show that 8-oxo-G containing oligomers in pol-β of eukaryotes 
accommodates the 8-oxo-G•C bp better than 8-oxo-G•A mismatch that is opposite of what 
is found for the bacterial polymerase BF.63  
The hydantoin lesion Sp is known to be a substrate for E. coli Fpg (MutM); 
however, the excision of Sp opposite A was less than that opposite C, though greater than 
removal of 8-oxo-G in these base pairs.64 Endonuclease VIII (Nei), a bacterial DNA 
glycosylase, can also remove the hydantoin lesions that have a WC hydrogen-bonding 
face.65 Sp was detected on chromate oxidation of repair-deficient (Nei−) E. coli by mass 
spectrometry. Mammalian orthologs of E. coli Nei are called Nei-like (NEIL) and include 
a family of enzymes consisting of NEIL1, NEIL2, and NEIL3.66-68 NEIL1 and NEIL2 
operate on lesions in ssDNA, dsDNA, and bubbled structures to remove the hydantoin 
lesions.69, 70 NEIL3 is found in cancerous or proliferating cells where its expression is 




indicate identification of the damaged base and flipping the base out of the helix into the 
substrate binding pocket followed by cleavage of the N-glycosidic bond.72-74 
NER is generally a repair pathway for bulky adducts of cyclobutane pyrimidine 
dimers, DNA-protein crosslink (DPC), and bulky alkylated adducts as it removes short 
DNA strands containing lesions.75 However, they seem to act as a ‘back up’ repair 
mechanism to mediate excision of 8-oxo-G in mouse cells lacking OGG1.76, 77 NER is a 
major repair pathway in neurons that requires TFIIH transcription-repair complex with 
helicase activity that unwinds the DNA for repair.78 The UvrABC proteins initiate and 
function in a coordinated fashion in prokaryotes to locate and excise lesion-containing 
DNA by NER.79, 80 It was found that both the 8-oxo-G, hydantoin products and the bulky 
Sp-amine adducts were recognized by UvrABC in NER (Figure 1.4).81 Thus, these 
oxidation products are reminiscent of both NER and BER pathways. 
 
Detection methods 
Several biological and chemical methods have been used to detect or quantify the 
damaged nucleobases and nucleosides. The biological methods include the comet assay,82 
ELISA,83 and 32P post -labelling methods.84 In the comet assay, the DNA with strand breaks 
migrates faster than normal DNA to form a comet-like streak on a gel, and this was first 
observed using fluorescence.85, 86 The 32P postlabeling method involves enzymatic 
digestion of DNA to nucleoside-3’-monophosphates that are radioactively labeled by T4- 
polynucleotide kinase and [γ32P]-ATP. The nucleoside-3’,5’-biphosphate adducts formed 
are separated by thin-layer chromatography (TLC).87 Other methods include 
































Figure 1.4. A representation of the NER pathway involved in the identification and 
excision of damaged bases. The labels A and B indicate UvrA dimer and UvrB protein 








spectrometry (MS/MS) as a sensitive and selective method used in detection of lesions.89  
Recently, fluorescent probes that recognize 8-oxo-dG have been developed.90-92 
Antibodies have been used for detection; however, they have certain limitations 
with respect to the timeline of generation and the requirement of animal or cell lines for 
discovery, and production and also develop an immunological response. Antibodies can be 
derivatized with small-molecule dyes using an amine linkage and these antibodies can 
differ in their properties from one lot to another or require secondary antibodies as an 
alternative for detection. Antibodies are byproducts of an animal’s immune response, and 
therefore, have batch-to-batch variations. Recently, Trevigen has launched a mouse anti-
8-oxo-dG monoclonal antibody that can detect 8-oxo-dG in DNA at very low nM 
concentrations.  
A controlled combinatorial method using nucleic acids might be advantageous for 
detection. Nucleic acids are robust binding agents with great shelf-life and easy production 
and they do not require an animal host in production, and can be derivatized easily, unlike 
antibodies. 
 
SELEX technology and aptamers 
Nucleic acids are versatile macromolecules that function as carriers of genetic 
information, gene regulation, or catalysis and therefore have garnered a great deal of 
attention in recent years.93-96 These nucleic acids have a propensity to fold in a specific and 
intricate three-dimensional manner. The structure, variability, and adaptability of these 
molecules define their functional diversity. Nature has not disregarded this biomolecular 




Riboswitches are known to regulate gene expression by a change in conformation mediated 
by binding to a metabolite, in response to physiological conditions.98, 99 The sparked 
interest toward these macromolecules is due to an ever-increasing number of discoveries 
with catalytic or binding function. These so called “functional nucleic acids” are also 
derived by in vitro selection.  
An iterative method for in vitro selection of functional nucleic acids was introduced 
and called ‘systematic evolution of ligands by exponential enrichment’ (SELEX). SELEX 
experiments were first performed in 1989-1990 by three different groups Oliphant et al.,100 
Ellington and Szostak,101 and Tuerk and Gold,102 separately. The products of selection were 
called ‘aptamers’ (aptus means ‘to fit’ and meros means ‘piece or part’). The first RNA 
aptamer was developed by Tuerk et al. for bacteriophage T4 DNA polymerase (a protein) 
and by Ellington for organic dyes (small molecules). The first DNA aptamer was reported 
for adenosine and ATP (KD 6 µM).103 The choice of either an RNA or DNA aptamer 
depends on practical considerations and final applications of the system. 
The aptamer functionality is based on the 3D-structures characterized by stems, 
loops, bulges, hairpins, pseudoknots, triplexes, or quadruplexes formed by interaction with 
a target. The intermolecular interaction or binding between the aptamer and the target 
results from structural compatibility, complementarity in shape, stacking interactions 
between aromatic groups, electrostatic interactions between charged groups, van der Waals 
interactions, and hydrogen bonding or a combination of these effects.104-108 
Aptamers have been selected for a wide variety of targets that include small 
molecules and large proteins to a whole cell of interest.109, 110 Initially, aptamers were 




acids,114-117 antibiotics,118-120 and nucleotides.103, 121, 122 Larger targets include co-
factors,123-126 proteins,127-129 cells,130-132 viruses,133-135 and bacteria.136, 137 According to an 
aptamer database, most aptamers are developed as RNA aptamers with preference for large 
targets, especially proteins. These macromolecules with various amino acids have more 
functional groups and structural motifs that resulting in a higher probability of finding 
sequences that can interact with target via various interactions (Figure 1.5). Despite this 
trend, there is an urge to pursue small molecule-binding aptamers. These smaller targets 
play an important role in biological process and can help understand several intricate 
physiological process. Aptamers for detection of carcinogens and metal ions might have 
several applications that will be discussed towards the end of this chapter. The smallest 
known molecular target for an aptamer selection is ethanolamine (KD of 6 nM); however, 
recently aptamers have also been selected for various cations.138 
A typical SELEX process is universally characterized by repetition of five steps: 
binding, partitioning, elution, amplification, and conditioning (Figure 1.6). Four important 
factors are involved in designing the pool, namely: type of randomization, length of 
randomization, benefit of constant regions, and chemistry of the pool.139 The most 
successful aptamers have been selected from 1 in 109 to 1 in 1013 molecules from a starting 
random library.140, 141 Each oligonucleotide has a random region with 20-80 nt that is 
flanked by regions of fixed sequences of 15-20 nt and that are primer binding sites during 
amplification. The shorter randomized libraries are manageable and cost effective for 
synthesis. However, the larger randomized libraries provide sequence and structural 
diversity.139 Since the library is commercially synthesized, a large-scale amplification of 



















Figure 1.5. The breakdown of aptamers into DNA and RNA (above) and the distribution 











Figure 1.6. A typical SELEX cycle showing five steps: (i) binding to the target, (ii) 
partition of the bound and unbound sequences, (iii) elution of the bound sequences, (iv) 
amplification of eluted strands by PCR, and (iv) conditioning of dsDNA to convert to 










eliminate damaged DNA synthesis products. Initial amplification of the pool also provides 
multiple copies of the original sequence that can serve as templates. The dsDNA is either 
transcribed to RNA by T7 RNA polymerase for RNA SELEX or converted to ssDNA and 
used for DNA SELEX. Because amplification by PCR introduces some level of mutation, 
the term “evolution” aptly describes the selection and mutation process. 
The pool or library is incubated with a target under specific buffer, temperature 
conditions, and incubation time that depends on the requirements for the particular target. 
The presence of monovalent cations in the buffer reduces nonspecific binding, and for 
some targets, divalent cations are important to form the complex. The selection starts with 
a low ratio of library to target in order to bind all ligand molecules to target. The initial 
rounds are less stringent and have long incubation times with the target.  
Negative selection is done in the absence of target to eliminate nonspecific binders 
or the background strands.142 The nonspecific binders are predominant in the initial rounds 
and hence, multiple rounds of SELEX are performed to eliminate these background 
strands.143 Later rounds are made more stringent to obtain specific binders by changing 
buffer composition, incubation times, or decreasing target concentrations. There is an 
exponential increase in selected sequences as specific binders during the later rounds of 
SELEX.144, 145 This justifies the term “exponential” as there is an exponential increase in 
binding affinity in the SELEX acronym. 
After incubation, separation of the bound aptamer-target complex is done from 
unbound sequences by various partitioning methods. The conventional method used for 
partition included affinity chromatography using agarose or sepharose146 or ultrafiltration 




methods in SELEX depending on the target.110 Some of the most common ones include: 
capillary electrophoresis (CE)-SELEX where partition is done using CE,147 covalent 
SELEX where the aptamers containing reactive groups link covalently to a target,148 and 
cell-SELEX generates aptamers for a specific cell of interest especially cancer cell lines.149 
FluMag SELEX is recently developed where the target is bound to magnetic beads and the 
library is modified with fluorophore for quantification purposes150 and structure-switching 
SELEX that immobilizes the library on the column instead of a target.151 Recently, next 
generation SELEX was done using a designed library that tiles through mRNA sequence.152  
The bound sequences are eluted from the column by using denaturing conditions 
like heat treatment150 or adding denaturing reagents like urea,153 sodium dodecyl sulfate 
(SDS),154 or EDTA155. These eluted rare strands are amplified by PCR and the amplicons 
are further conditioned to purify the relevant single-stranded sequences. The amplified pool 
needs to be prepared for the next cycle, and conditioning involves converting these dsDNA 
to form RNA or ssDNA. Transcription is done for conversion of dsDNA to RNA aptamers, 
whereas, separation of dsDNA is done to generate ssDNA aptamers. This can be achieved 
in several ways that have been developed and widely used. The biotinylation of an 
unwanted or antisense strand can aid in removing this strand on the streptavidin column.156 
Another method involves using a 3’-terminus ribose residue (rU) in the antisense primer 
that cleaves the dsDNA using NaOH (Figure 1.7).157 Denaturing PAGE is the most 
commonly used method to convert the dsDNA into ssDNA and is based on detectable 
differential migration of two strands by UV shadowing.158, 159 This principle can also be 
applied to fluorescent labeled sense primer that are used in PCR and strand separation can 




























Figure 1.7. The pictorial representation of the one of the several methods of conditioning 
that uses ribonucleoside (rC) and treatment with NaOH to further purify the ssDNA pool 
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(HEGL) spacer poly-A20 tail to increase the length and aid in separation of the strands.160  
Another method involves the use of lambda exonuclease that uses a 5’-phosphorylated 
antisense strand of dsDNA as a substrate (Figure 1.8).161 
After 6-15 iterative rounds of selection, amplification, and conditioning, the target-
binding ligands are enriched and the complexity of the starting library is greatly reduced. 
The final pool is PCR amplified, cloned into a vector, and the colonies are sequenced. 
Sequences for around 50 colonies are identified and sequence alignment is done to 
determine the homology in sequences. The aptamers are grouped based on most identical 
sequences. The analysis of secondary structure of aptamers by M-fold can provide 
information on the relevant structures for binding. 
Subsequently binding studies are performed to determine the affinity of the 
aptamers to the target. The dissociation constant (KD) is an important and characteristic 
parameter for an aptamer that does not depend on size, quantity, or complexity of the target. 
A lower KD value for an aptamer indicates high binding affinity to the target. Several 
methods for determining the KD have been developed that include separation-based 
methods,162-164 spectroscopy-based methods,165-168 and mass-sensitive surface-based 
methods.169, 170 Most of the separation-based and mass-sensitive methods are challenging 
to use for the smaller targets as they have less effect on the separation of the complex and 
the aptamer. 
The spectroscopy-based methods include fluorescence intensity method where the 
aptamer or target fluorescence is quenched or increased upon binding.165 UV-vis 
absorption is based on the change in wavelength or intensity of absorption of the aptamer 



























Figure 1.8. The pictorial representation of the one of the several methods used in 
conditioning the dsDNA pool to convert and purify to ssDNA pool before use in the next 
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dichroism (CD) spectra may change significantly because of the difference in conformation 
upon binding to target.168 The method used for KD determination entirely depends on the 
type of target used, and sometimes several methods need to be tested in order to choose the 
one that works.  
Post-SELEX modifications are done to either increase the stability of the aptamer 
or optimize binding parameters to the target. Sequences are truncated to narrow down the 
binding region of the aptamer to the target. The regions that do not account for any direct 
interaction with the target, or for folding into a structure that binds the target are truncated. 
There are several examples reported where truncated aptamers have higher binding 
affinities.171, 172 An aptamer binding affinity or specificity can be increased by a selection 
process in which the existing aptamer is modified or mutagenized in order to generate a 
new diversified library.122 Mutagenesis can be done by error-prone PCR173 or random 
fragmentation on the preselected aptamer.173  
In order to enhance biostability of RNA aptamers, 2’-OH modifications are done to 
2’-F or 2’-NH2 to protect from nuclease degradation.174, 175 Locked nucleic acids (LNA) 
can also be used to prevent nuclease degradation.176 However, DNA aptamers offer an 
advantage of stability as compared to RNA aptamers. Exonuclease degradation can be 
prevented by either 3’-end (inverted dT or streptavidin-biotin) or 5’-end (polyethylene-
glycol (PEG), cholesterol, fatty acids) capping.177, 178 
Aptamers are recently applied for innovative applications in the field of chemical 
biology.179, 180 In therapeutics, several aptamers for their targets are being tested. In 2004, 
Macugen (Pegatnib) became the first and only know FDA approved aptamer-based 




epithelial growth factor (VEGF) aptamer is an active medical component in treatment. 
Aptamers, because of their small size, can penetrate into cells and tissues easily, and 
therefore can be used for in vivo imaging purposes.182 They can also be used as molecular 
detection systems for purification, separation, and quantification of analytes using CE and 
electrochromatography.183 Aptamers also play a very important role as biosensors and help 
in monitoring drug levels in blood, detecting environmental contaminants, or monitoring 
carcinogens.  
Aptamer beacons also called signaling aptamers,184 aptamers coupled to quantum 
dots,185 gold nanoparticles,186 or electrochemical platform187 have established the role of 
aptamers in biosensing. Aptamers can be coupled with other functional moieties without 
affecting their ability to recognize a cognate target are used to develop regulatory elements 
called DNAzymes or aptazymes.188 Allosteric approaches to modular aptamers have been 
developed for sensing. For example, malachite green (MG) aptamer coupled to a flavin 
mononucleotide (FMN) aptamer where the fluorescence increases only if FMN is bound 
to the domain of the coupled aptamer.184 Intramers, aptamers binding to intracellular 
protein targets, are important tools in protein-based networks in vivo.189  
Aptamers have limitations in terms of their tertiary structure that is dependent on 
solution conditions. The other limitations like nuclease degradation and chemical diversity 
have been combated by using base modifications or spiegelmers. Additionally, there are 
no immunological responses to aptamers as compared to antibodies. Aptamers can be 
produced in large scale, easily derivatized regioselectively for detection using dyes, and 
they are stable indefinitely at room temperature when dry. Aptamers, in the coming years, 




infectious diseases. The understanding of riboswitches is also likely to spur development 
in the field of aptamers. Since they mimic features of monoclonal antibodies, aptamer 
technology is developing into a major tool with commercial potential. 
The aim of my research initially was to study the products of guanine oxidation 
using nickel-mediated transition metals. Chapter 2 is aimed at studying damaged guanine 
oxidation products and to optimize the oxidation conditions to generate 2-Ih as an exclusive 
product of oxidation of guanine in nucleoside and ssDNA. 
The Burrows lab developed various methods for detection of the various damaged 
bases. One of the methods has been using nanopore technique to study modified bases or 
damages in the DNA by studying the variations in current-time traces.190, 191 Aptamers have 
been used for detection of a wide variety of targets, including nucleosides. The ultimate 
goal of my research is to select sensors that are selective to the damaged nucleobases that 
are the products of repair pathways in the cell. The aim was to develop a SELEX method 
that can be applied to the challenging modified nucleobases and nucleosides.  
In Chapter 3, I will discuss in detail, structure-switching SELEX applied to select 
aptamers for the various damaged guanine oxidation products as targets. The sequences 
identified and the binding studies of designed sensors are also discussed in this chapter. 
The concentrations of the target is low: 8-oxo-dG in a cell is about 8 nM, whereas the 
hydantoin dSp is ~500 nM.44 All the damaged bases are present in lower concentration than 
the normal bases and hence the need for new selective methods for detection with high 
binding affinity (low KD value). 
Sensors are reported for 8-oxo-G as a nucleoside and within a DNA strand. The 




was developed to detect 8-oxo-G in a triplex with a detection limit of 5 nM._ENREF_192 
Aptamers have not been reported so far for the hydantoin lesions, dSp (both diastereomers) 
and Sp nucleobase. The structure-switching method is being applied for the first time to 
develop aptamer sensors against these damaged bases. Through a series of rounds of 
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COMPARISON OF TRANSITION METAL-MEDIATED OXIDATION  






Chemical modification of guanine (G), the most readily oxidized nucleobase in 
DNA, has been linked to aging, cancer, and degenerative diseases.1-4 The constant attack 
by endogenous and exogenous oxidants on guanine generates various oxidation products 
(Figure 2.1).5 Among these products, 8-oxo-7,8-dihydroguanine (8-oxo-G), guanine-
derived 2,6-diamino-4-hydroxy-formamidopyrimidine (FAPy-G),6-8 
spiroiminodihydantoin (Sp),9 and oxazolone (Z)10 have been found in vivo. The normal 
level of 8-oxo-G, the most common oxidation product of guanine, is 0.3 - 4  lesions per 106 
dG nucleosides,11 and it has been used as a biomarker of oxidative stress in cells.12  
The various oxidation products formed are due to hydroxylation or 
perhydroxylation at the C-5 or C-8 positions of G. For example, the C-5 pathway involves 
loss of one electron from guanine leading to the formation of the guanine radical cation 
(G˙+) that has a pKa of 3.9;13 G˙+ undergoes rapid deprotonation in the nucleoside form, 
although its lifespan may be prolonged in duplex DNA .14 The neutral guanine radical 
(G˙)15-17 is attacked by molecular oxygen 18-20 or superoxide anion (O2˙-)17, 21, 22 and results 
41 




















    
in a cascade of decomposition reactions leading to formation the of imidazolone (Iz) and 
eventually oxazolone (Z) products (Scheme 2.1).23-25 
 On the other hand, the guanine radical cation (G˙+) can be trapped by H2O at C-
8,13 followed by the deprotonation and formation of an intermediate adduct (8-OH-G˙)26 
that is prone to further oxidation and tautomerization leading to 8-oxo-G. Under reducing 
conditions, one-electron reduction of 8-OH-G˙ followed by ring opening leads to FAPy-G. 
Both 8-oxo-G and FAPy-G are formed during radiation damage to DNA.4,8  8-Oxo-G has 
a reduction potential of 0.74 V versus NHE,27 and because this is ~0.55 V lower than that 
of G (E = 1.29 V vs. NHE at pH 7), further oxidation can readily occur yielding the 
spirocyclic base Sp as well as guanidinohydantoin (Gh).27,28  Both of the hydantoin lesions 
are known to be highly mutagenic (Scheme 2.2).28-30 
A wide range of aqueous oxidation systems, from reactive oxygen species (ROS)31 
and photochemical oxidants32 to transition metals, 25, 33-36 are known to react with the 
electron-rich guanine (Table 2.1). Among the sulfoxyl radicals, the sulfate radical anion 
(SO4.-) is the most potent oxidant with a redox potential of 2.43 V vs. NHE at pH 7, and 
acts by a one-electron abstraction mechanism.37 Another relevant oxidant is singlet oxygen 
formed by photoexcitation of photosensitizers such as Rose Bengal (RB).32 The quantum 
yield of RB for singlet oxygen production is 0.76 in water.38 Singlet oxygen can potentially 
act by four-electron oxidation of G, bypassing 8-oxoG to yield hydantoin products 
directly.39  
Furthermore, several transition metal ions act as promoters of nucleic acid 
oxidation. The simplest of the oxidant mechanistically is hexachloroiridate, IrCl62-, a water- 
soluble, one-electron oxidants with a redox potential of 0.9 V vs. NHE.40 In the presence 
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Scheme 2.1. C-5 pathway for oxidation of 2’,3’,5’-tri-O-acetyl-guanosine. 
 
 












Table 2.1. Aqueous oxidation systems and their reduction potentials vs NHE at pH 7. 
 
Oxidation System Oxidant E1/2 (V vs. NHE) at pH 7 
      
Na2IrCl6 e- 0.9 
K2S2O8/ hν (256 nm) SO4.- 2.43 
Rose Bengal/ hν (360 nm)     1O2 NA 
CoCl2/ KHSO5 SO4.- >2.0 
Ni(II)CR/ KHSO5 L4-Ni-O-SO3. >2.0 











    
of transition metals such as cobalt (II) and nickel (II), oxone (KHSO5) causes site-specific 
guanine oxidation.41-43 Metal-catalyzed decomposition of KHSO5  generates SO4.- that is 
responsible for the oxidation of G.41 CoCl2/KHSO5 generates highly diffusible sulfate 
radicals that induce guanine-specific modification in bulges, loops, and single-stranded 
DNA (ssDNA).34 
It has been reported that simple nickel salts combined with H2O2 result in the 
formation of 8-oxo-G as the oxidation product.44, 45 Specifically, nickel (II) complexes that 
are four-coordinate, and square planar allow nickel binding to chromatin and are known 
for their toxicity and carcinogenicity.46, 47 These complexes can facilitate oxidization of the 
DNA, causing strand breaks, oxidative base damage, and DNA-protein crosslinks.48, 49 The 
nickel complexes, however, do not deform the nucleic acids’ structure in the process of 
recognition.50 Certain ligands, like peptides, coordinate to nickel (II) to enhance the metal 
reactivity by stabilizing the +3 oxidation state of the metal to promote oxidation.51-53 The 
ligand surrounding the metal and the redox properties of the metal play an important role 
in the determination of oxidation by these nickel macrocycles. Nickel tetraazamacrocyles 
that possess strong in-plane donor ligands and vacant coordination sites mediate oxidative 
damage of guanine with peracids like KHSO5.35 NiCR is a square planar complex with a 
+2 charge and is a 14-membered macrocycle with nitrogens present as pyridine or imine 
groups. NiCR, unlike nickel peptides, does not react in the minor groove under low salt 
concentrations.54 Base damage occurs in regions where guanines are solvent accessible and 
hence NiCR acts as a probe in the determination of the three-dimensional folded structures 
of DNA and RNA.53, 54 
NiCR is thought to prefer oxidation at exposed Gs by binding to the most basic site, 
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N7 in guanine, thus delivering the oxidant to the exposed base by direct metal coordination 
(Figure 2.2).35, 55 The intermediate is proposed to be an octahedral nickel (III)-bound sulfate 
radical, in which the two additional ligands, guanine and oxidant, are cis-coordinated 
(Scheme 2.3). Subsequent reductive elimination of these groups results in an oxidized G in 
DNA that leads to strand scission upon treatment with hot piperidine.35, 50, 56 The flexibility 
of the macrocyclic ring is important for cis-coordination of the guanine and oxidant around 
the metal ion. A bifunctional oxidant containing both a ligand (sulfate) and an oxygen atom 
donor might be effective to bind and stabilize the nickel (III). NiCR differs from 
CoCl2/KHSO5 in its mechanism of oxidation and guanine recognition.  NiCR coordinates 
to N7 of guanine whereas Co (II) interacts with the π- face of the purine ring. The difference 
in mode of recognition is attributed to free SO4.- induced by CoCl2 as compared to nickel-
coordinated SO4˙-. 34  
Square planar nickel peptide complexes, NiIIGly-Gly-His and NiIIArg-Gly-His, 
appear to generate a similar reactive complex with SO42- radical via autoxidation of sulfite. 
In this mechanism, Ni(II) catalyzes the formation of HSO5- via autoxidation of HSO3-. 
Curiously, the product of G oxidation by the NiIIGly-Gly-His/ HSO3-/O2 system appears to 
be 8-oxo-G, which has not been observed from G oxidation by the NiCR/ KHSO5 system. 
Despite its popularity as a structural tool, the NiCR/KHSO5 remained elusive in 
terms of its eventual chemistry with G. The final product formed by G oxidation in 
oligodeoxynucleotides, with NiCR/KHSO5 system results in base-specific cleavage upon 
alkaline treatment.35 The final product formed had a mass that was higher than that of 
starting material by 34 and had two possible structures.57 The transient product, G+16 was 
thought to be formed by hydroxylation of G.58 Three other laboratories have also observed 
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this mass increase. 
Pratviel, Meunier, and coworkers studied the oxidation of G by Mn-
TMPyP/KHSO5 and found a minor product that gave the mass increase of G+34.59, 60 Based 
on 18O labeling studies in the Burrows laboratory, the new compound G+34 was proposed 
to be the result of two oxygens being incorporated from H2O.60 They suggested that the 
compound arises from the hydroxylation at C-5 of the (G)+ intermediate, leading to an 
unstable compound with one labeled oxygen atom from H218O at C-5. This intermediate 
was expected to rearrange at physiological pH into a Sp-like structure.14 The Rokita 
laboratory also found the mass of G+34 as the major product of  DNA oxidation with a 
dinuclear copper complex, [Cu2II (PD ̒ O)(H2O)2]3+ where PD ̒ OH is a pyridylalkylamine 
containing binucleating ligand.61 More recently, epoxidation of G by dimethyldioxirane 
(DMDO) was studied by the Ball laboratory. An oxygen atom transfer reaction gives 5- 
carboxamido-5-formamido-2-iminohydantoin (2-Ih) as the only product, and its structure 
was characterized by the Ball laboratory.62, 63 
 In this work, we studied the oxidation chemistry of both a suitably protected 
nucleoside, namely, 2’,3’,5’-tri-O-acetylguanosine, and a 15-mer ssDNA containing a 
single 2’-deoxyguanosine site with various oxidants, including  NiCR/KHSO5, and the 
results were compared. Under specific conditions studied, oxidation of G gave 2-Ih as the 
only isolable product in both nucleoside and ssDNA. Hence, 2-Ih may be considered as a 












Guanosine hydrate, KHSO5 (oxone), CoCl2, Na2IrCl6, Rose Bengal, K2S2O8, 
EDTA, HEPES, sodium chloride, and sodium phosphate were purchased from 
commercially available sources. NiCR was synthesized by the method of Karn and 
Busch.64 The oligodeoxynucleotides (ODNs) were obtained from the DNA Core facility at 
the University of Utah and were 5’-end labeled using T4 polynucleotide kinase and [γ-32P] 
ATP following literature protocols.65 Radioactivity was quantified using a Beckman 




ESI mass spectra were obtained on a Micromass Quattro II spectrometer. HPLC 
analyses of nucleoside reactions were analyzed on a Beckman System Gold 126NM 
solvent module attached to a Beckman 168NM diode array detector with a Varian C-18 
analytical reversed-phase column (5 µm, 250 mm × 4.6 mm) or Phenomenex Synergi polar 
reversed-phase column (4 µm, 250 mm × 4.6 mm). All solvents were HPLC-grade that 
were filtered and sonicated before use. All aqueous solutions were prepared from purified 
water (Nanopure, Synbron/ Barnsted).  
The ODN reactions were HPLC analyzed using a Beckman System Gold 126NM 
solvent module attached to a Beckman 166NM diode array detector running a Dionex 
DNAPac PA-100 analytical ion-exchange column (4 mm × 250 mm). Synthesis of 2’,3’,5’-




    
Oxidation of (OAc)3G  
Oxidation with NiCR/KHSO5: Condition A: 3 mM (OAc)3G was incubated with 
12 µM NiCR and 4 mM KHSO5 in 75 mM sodium phosphate (NaPi) buffer at pH 7.4 and 
37 ºC for 30 min. After 30 min, the reaction was quenched with 40 mM HEPES. The 
reaction mixture was analyzed by HPLC using a polar-reversed- phase column with a linear 
gradient of 1% solvent B to 70% solvent B over 65 min at 1 mL/min monitored at 245 nm 
wavelength. Solvent A was 0.1% aqueous CF3COOH (TFA); solvent B was 0.1% TFA in 
CH3CN. Condition B: 3 mM (OAc)3G was incubated with 60 µM NiCR and 4 mM KHSO5 
added in intervals every 3 min in 75 mM NaPi at pH 7.4 and 37 ºC. The reaction was 
quenched with 40 mM HEPES after 30 min. 
Oxidation with CoCl2/KHSO5: 3 mM (OAc)3G was incubated with 12 µM CoCl2 
and 4 mM KHSO5 in 75 mM NaPi at pH 7.4 and 37 ºC for 30 min and the reaction was 
quenched with 40 mM HEPES. 
Oxidation with Na2IrCl6: 3 mM (OAc)3G was treated with 6 mM Na2IrCl6 in 75 
mM NaPi at pH 7.4 and 37 ºC and was quenched with 60 mM EDTA after 30 min. 
Oxidation with singlet oxygen: 3 mM (OAc)3G was incubated with 300 µM RB in 
75 mM NaPi at pH 7.4 and was irradiated by a sunlamp emitting 360 nm for 30 min at 37 
ºC at a distance of ~8 cm above the reaction. The RB was removed by passing the reaction 
mixture through a Nap-25 column following the manufacturer’s protocol. The fractions 
collected were analyzed by HPLC. 
Oxidation with K2S2O8: 3 mM (OAc)3G was treated with 70 mM K2S2O8 in pH 7.4 
and 75 mM NaPi buffer under 256 nm light for 30 min at a distance of 3 cm.  
Each reaction was analyzed by HPLC using a polar-reversed phase column with a 
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linear gradient of 1% solvent B to 70% solvent B in 65 min at 1 mL/min. Solvent A was 
0.1% aqueous TFA; solvent B was 0.1% TFA in CH3CN. The chromatogram was recorded 
while monitoring absorbance at 245 nm for product quantification. The reaction mixture 
was analyzed by LC-MS for product identification. 
 
 
Oxidation and piperidine-induced cleavage of ODN 
The ODN sequence used was a 15-mer with a single G at the eighth position from 
the 5’ end. The sequence was 5’-TTT TTT TGT TTT TTT-3’ (5’-T7GT7-3’). Oxidation 
reactions were carried out on 5 µM ODN, 5 µM NiCR with different concentrations of 
KHSO5 ranging from 5 – 500 µM in 10 mM NaPi and 100 mM NaCl (pH 7.4). Reactions 
were quenched with 50 mM HEPES after 30 min. Piperidine cleavage reactions were 
carried out in 0.4 M piperidine at 90 ºC for 30 min.  Finally, the smaller DNA fragments 
were separated by PAGE (20% polyacrylamide/ 7 M urea) and visualized by storage 
phosphor autoradiography (Molecular Dynamics Storm 840) and quantified with Image 
QuaNT version 5.2 software.  
Oxidation with NiCR/KHSO5: 5 µM ODN was incubated with 5 µM NiCR and 
then reacted with 250 µM KHSO5 in 10 mM NaPi and 100 mM NaCl buffer of pH 7.4 at  
37 ºC for 30 min. 
Oxidation with Na2IrCl6: 5 µM ODN was allowed to react with 750 µM Na2IrCl6 
in 10 mM NaPi and 100 mM NaCl buffer at pH 7.4 at 37 ºC for 30 min. 
Oxidation with singlet oxygen: 5 µM ODN was incubated with 300 µM RB and 
irradiated with sunlamp in 10 mM NaPi and 100 mM NaCl buffer of pH 7.4 at 37 ºC for 30 
min.  
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All the above reactions were analyzed by HPLC using an ion-exchange column 
with a gradient of 15% solvent B to 100% solvent B in 30 min at a flow rate of 1 mL/min. 
Solvent A is 90% ddH2O; solvent B is 1.5 M sodium acetate at pH 7 and 10% CH3CN. The 
chromatogram was recorded by monitoring absorbance at 260 nm.  
 
Results and discussion 
Oxidation of (OAc)3G  
The transition metal complex Na2IrCl6 is a water-soluble, non-nucleoside binding, 
outer-sphere, one-electron oxidant.40 The oxidation of (OAc)3G with Ir (IV) results in the 
formation of Sp at pH 7. CoCl2 exists as [Co(H2O)6]2+ in aqueous solutions, and its higher 
oxidation state of Co (III) is extremely unstable at pH 7 and this initiates the decomposition 
of KHSO5 that yields the potent sulfate radical. The freely diffusible SO4˙- results in G-
oxidation, yielding Sp as the major product at pH 7, and other oxidants like Gh and Iz as 
minor products, whereas in the square planar NiCR, two possible roles of Ni(II) have been 
proposed; one is the redox role where formation of a higher oxidation state is part of the 
catalytic cycle. The other role is Ni(II) acts as a Lewis acid for the activation of the peracid 
toward oxidative attack on the G nucleoside. It is well documented that Ni(II) ions bind to 
the N7 of G.68 The proposed intermediate is an octahedral Ni (III) species, in which two 
additional ligands, guanine and an oxidant monopersulfate, are cis-coordinated to nickel. 
The oxidation of (OAc)3G with NiCR/KHSO5 yielded a mixture of oxidation products that 
were well separated on the polar-reversed phase column (Figure 2.3). The products 2-Ih, 
Sp and Gh each exist as two diastereomers.  
LC-ESI+-MS allowed the identification of the products by comparing the retention  
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Figure 2.3. HPLC-chromatogram of (OAc)3G oxidation by NiCR/KHSO5. The products 
have been identified by LC-ESI+-MS. The oxidation products 2-Ih, Gh, and Sp give 2 

























    
time, UV-vis spectra, and mass shown in the Appendix. The masses obtained from 
oxidation of (OAc)3G with NiCR/KHSO5 by LC-ESI+-MS are shown in Table 2.2. Apart 
from the starting material (OAc)3G with [M+H]+ of 410.0 amu, (OAc)2G was also seen 
with [M+H]+ of 368 amu. All products were quantified by integrating the HPLC peak areas 
that were normalized through each compound’s unique molar extinction coefficients (ε) at 
245 nm shown in Table 2.3.69 The molar extinction coefficient (ε) for 2-Ih was assumed to 
be similar to Sp at 2.24 × 103 M-1cm-1. 
Two strategies were employed to form 2-Ih as a major product. The first was to 
increase the NiCR concentration, and the second was titrating 500 µM KHSO5 at regular 
intervals of every 3.75 min for a total reaction time of 30 min. The latter yields the 2-Ih 
product exclusively, and the two diastereomers were well separated on the polar-reversed 
phase column (Figure 2.4). The two peaks from the reaction of 3 mM (OAc)3G with 60 
µM NiCR and 4 mM KHSO5 (added in aliquots) were collected to determine their mass. 
Both peaks in the chromatogram increased with increased NiCR concentration and titration 
of KHSO5 at regular intervals, exclusively yielding the compound with mass of 443.9.  
8-Oxo-G was not detected either by CoCl2/ KHSO5 or NiCR/KHSO5 at pH 7.4. Homolytic 
cleavage of K2S2O8 by photolysis generates a clean source of sulfate radical. The oxidation 
of (OAc)3G results in formation of 70% Sp, 25% Gh and 5% Iz. Singlet oxygen yields 85% 
Sp and 25% Gh as the oxidation products of (OAc)3G. Figure 2.5 compares relative product 






    
 
 
Table 2.2. Identification of products by LC-ESI+-MS on oxidation of (OAc)3G  





















































Figure 2.4. HPLC chromatogram of (OAc)3G oxidation by increased NiCR concentration 









































    
Oxidation of 5’-T7GT7-3’ ODN 
 Oxidation of a 15-mer ODN followed by piperidine treatment resulted in exclusive 
cleavage of the strand at the G site, as analyzed by polyacrylamide gel electrophoresis 
(Figure 2.6). Lanes 1-6 show the oxidation of 5 µM 5’-T7GT7-3’ by 5 µM NiCR with 
increasing concentrations of KHSO5 from 5 to 500 µM. Lane 7 shows a control study 
without addition of oxidant. Lane 8 is the Maxam-Gilbert G-lane.70 The G was cleanly 
oxidized at the concentrations of 125-500 µM.  
The reaction of 15-mer with NiCR/KHSO5 was analyzed on an ion-exchange HPLC 
column and yields 2-Ih as the major product (Figure 2.7). The 2-Ih mass was supported by 
ESI-MS+ with the mass of 4558.0 amu for peak 2 corresponding to oxidized ODN. Peak 1 
has the mass of 4524.0 for the standard 15-mer. 
The 15-mer reaction with iridium (IV) at pH 7.4 and singlet oxygen yielded Sp as 
the only product and the mass 4556.0 amu was confirmed by ESI+-MS. The relative product 




The oxidation of (OAc)3G yields a wide array of products that follow different 
oxidation pathways. Some oxidants follow the C-8 oxidation pathway and lead to the 
formation of Sp and Gh, with 8-oxo-G, the most common oxidation product, as an 
intermediate. The other oxidation pathway starting with C-5 leads to the formation of Iz 
and 2-Ih. Transition metals play an important role in formation of the oxidative products 
that depends on the coordination of the oxidant to the metal. The oxidation of the (OAc)3G  
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Figure 2.6. Gel analysis for oxidation and piperidine-induced cleavage of 5’-T7GT7-3’  
ODN. All the lanes were piperidine treated. Lanes 1-6: oxidation reactions with 5 µM 
ODN, 5 µM NiCR and increasing concentration of KHSO5 with lane 1-6 as 5, 25, 50, 125, 





































Figure 2.7. HPLC trace for oxidation of 15-mer ODN with NiCR/KHSO5. The HPLC- 
chromatogram represents a 15-mer standard (1) and reaction of NiCR/KHSO5 with 15-mer 

































    
with NiCR/KHSO5 yielded a wide range of oxidation products with two diastereomers of 
each Sp, Gh, and 2-Ih. 
Since no reducing or anaerobic conditions were used, the product FAPy-G was not 
observed.6-8 2-Ih was formed as the only oxidation product in (OAc)3G by increasing the 
concentration of NiCR and adding the KHSO5 in aliquots. The exact mechanism for this is 
still not clear, but we propose the cis-coordinated Ni bound by both sulfate radical and the 
N7 of G that further results in an acyl ring shift resulting in formation of 2-Ih.  
The oxidation of a 15-mer ssDNA containing a single G site also results in 
formation of exclusively 2-Ih. The NiCR complex was used as a probe for the structure of 
DNA and the previously unknown product from the piperidine cleavage site with a mass 
of M+34 can now be confirmed as the oxidation product 2-Ih. Thus, we conclude that 2-Ih 
is a two-electron oxidation product, whereas Sp and Gh are four-electron oxidation 
products of G. Furthermore, Spred can readily be hydrolyzed and the ring opening occurs 
to give 2-Ih (M+34) and ring opening can result in two possible structures (a) and (b) as 
shown in Figure 2.9. The structure (a) has been confirmed through NMR studies performed 
by the Ball Laboratory.62 Further studies have been carried out in our laboratory on 
oxidation of dG with copper-mediated Fenton chemistry in the presence of reductants such 
as ascorbate or N-acetyl-cysteine that are used for reduction of metal ions. It has been 
shown that 2-Ih is a major product of oxidation in nucleosides, ssDNA and dsDNA, 
following the C-5 pathway for its formation.70 Currently, the lab is also conducting 
experiments with X-rays to understand how ubiquitous is formation of 2-Ih. The formation 
of 2-Ih as the major product in nucleoside and ssDNA in the presence of redox-active 
metals suggests that 2-Ih is a primary DNA lesion. 
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SELECTION OF DNA APTAMERS FOR OXIDIZED GUANINE 






Several modifications have been made to the typical SELEX procedure, since its 
invention.1-6 The flexibility offered with respect to methodology is an enormous advantage 
of SELEX that was explained in Chapter 1.  Several alterations have been made either to 
generate improved aptamers or simplify the SELEX procedure.7, 8 Some of these 
refinements include changes to target immobilization, nucleic acid library, selection 
stringency, amplification, or monitoring the enrichment. Nucleic acids have the propensity 
to hybridize to complementary oligonucleotides, which has been applied for construction 
of  molecular probes.9, 10 However, nucleic acids developed as aptamers have also been 
adapted selectively to undergo “induced fit” conformational change in the presence of 
cognate ligands.11 The aptamers can compete and switch from DNA/DNA duplex to 
DNA/target complex. The duplex is formed between the DNA library or aptamer and a 
small oligonucleotide moiety complementary to the aptamer. In the presence of a target, 
the aptamer prefers the aptamer-target complex and a switch in structure occurs. This 
switch of binding partners for aptamers has been widely studied by various groups and 
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referred to as structure-switching aptamers (Figure 3.1).12, 13 These aptamers have also been 
engineered to transduce this molecular recognition through signaling.3, 14 It is important to 
note that not all aptamers can be converted to structure-switching probes, thus one needs 
to perform structure-switching SELEX for these targets. 
The structure-switching principle was applied in our research to select aptamers for 
the targets. The five targets used for selection are the guanine oxidation products, 8-oxo-
dG and its nucleobase (8-oxo-G), dSp nucleoside diastereomers, and one Sp enantiomer 
(Figure 3.2) that are formed by reaction of various reactive oxygen species (ROS) with 
guanine.15-17 These targets are substrates for either BER or NER repair pathways that have 
been discussed in detail in Chapter 1. The above mentioned oxidation products are small 
molecules and possess technical challenges with performing SELEX.4, 18 The most crucial 
step for a successful aptamer selection involves the separation of target-bound and unbound 
species.19 Affinity chromatography, a conventional separation method, is used to 
immobilize target on column material such as sepharose or agarose.7, 20 However, chemical 
modification of the target is required to immobilize it on the column. Another disadvantage 
to chemical modification is that the library is exposed to the modified target, as opposed to 
the desired unmodified target, increasing the possibility of selecting sequences that display 
binding properties toward the linker arm or the modified target. Besides, a substantial 
amount of modified target is required to be synthesized in order to achieve sufficiently high 
loading of the column. These challenges along with target solubility issues at high 
concentrations have led us to use an alternative approach to select the aptamers. 
The selection strategy for aptamers is based on the work previously reported by 
Li,21 Stojanovic,22 and Stoltenberg23. The main difference in selection was the presentation 
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Figure 3.1. The structure-switching process of the aptamer from its complementary 




















Figure 3.2. Targets used to select aptamers by performing capture-SELEX. All these 











   
of target and the oligonucleotide library as compared to standard affinity chromatography. 
A special SELEX library was developed to enable the immobilization of the library instead 
of the target on the column. In one case, a competitor oligonucleotide complementary to 
the primer region was utilized (Figure 3.3a) and in another a centralized docking region 
(Figure 3.4a) was used to capture the library on the column. The two strategies along with 
different randomized libraries and docking regions are shown in Figures 3.3 and 3.4 and 
will be henceforth referred to as MS-SELEX, and YL-SELEX, respectively. 
 MS-SELEX has a special 72-mer ssDNA library that consists of a 30-nucleotide 
(nt) randomized region that is flanked by primer-binding sequences (PBS). An 18-mer 
capture or docking strand that is 3’-biotinylated is partially complementary to one of the 
primer regions (Figure 3.3b). This arrangement permits immobilization of the DNA library 
on a streptavidin-agarose resin column through DNA hybridization. In the presence of a 
target, the library sequences undergo structural-switching to form a DNA-target complex. 
The DNA eluted from the column by this switching mechanism is amplified to dsDNA and 
further converted to ssDNA library to be used for the next round of selection. 
YL-SELEX has a 94-mer ssDNA library that consists of a central 15-nt fixed 
sequence flanked by two random-sequence domains of 10 and 20-nt, each further flanked 
by PBS. The capture strand that is 5’-biotinylated with a poly-A linker attaches to the 
central 15-nt fixed region of the library (Figure 3.4b). Target-binding initiates structural 
changes and selective library sequences are eluted from the column. PCR amplification of 
the eluted strands and further conversion to ssDNA was conducted to proceed to the next 
round. YL-SELEX was used for the selection of aptamers for target 8-oxo-G to compare 
the aptamers with respect to MS-SELEX. Both MS-SELEX and YL-SELEX libraries were 
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Figure 3.3. Structure-switching strategy in MS-SELEX. (a) A pictorial representation of 
structure-switching strategy involved in MS-SELEX. (b) The sequences of random library, 


















Figure 3.4. Structure-switching strategy in YL-SELEX. (a) A pictorial representation of  
structure-switching strategy involved in YL-SELEX. (b) The sequences of random library, 








   
fluorescently labeled to monitor the amount of aptamer release from the column during the 
target binding step. 
The amplification of these released aptamers was done by PCR,24 using a 5’-cy3-
forward primer (FP) and a 5’-biotinylated reverse primer (RP). This resulted in 5’-cy3-
labeled sense strands and 5’-biotinylated antisense strands. Several methods have been 
used in literature protocols to convert dsDNA to ssDNA.25, 26 In our experiments, the 
conversion of dsDNA to ssDNA was done on the streptavidin agarose resin that captures 
the antisense strand. The sense strand was eluted from the column using NaOH that 
denatures the dsDNA, whereas the antisense strand remains on the column, because the 
biotin streptavidin interaction remains tight during the mild base treatment.  
The first few rounds of SELEX were performed in low stringency as individual 
sequences were not highly represented. In later rounds, as the high copy number of specific 
binders or functional sequences were obtained, stringent conditions were applied.27 Several 
rounds of SELEX with increased stringency results in enrichment of highly-selective 
functional sequences.28 Stringency in SELEX was introduced by gradually decreasing the 
concentration of target in consecutive cycles starting from 100-1 µM. Counter selection 
was done using similar target structures simultaneously present during detection in the 
initial and later rounds of SELEX.29 
Further, the selected binders were cloned to E. coli and sequenced. These selected 
sequences were aligned in the randomized regions and assigned to different classes based 
on the similarities. Post-SELEX modifications were done to obtain sequences with 
enhanced binding and specificity over the original sequences. These include truncating the 
original sequence and testing these new sequences for their binding affinities to the target. 
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Binding affinities of the selected sensors toward small molecule targets are 
measured by various methods.4 The most commonly used methods are mass sensitive 
surface-based,30 separation-based,31-35 or spectroscopy-based.36-38 We used a fluorescence-
based method to determine the binding affinity of the aptamer to the target. The aptamer 
served as a molecular recognition element, and the competitor or capture strand served as 
a signal transduction element. The capture strand was partially complementary and bound 
to the aptamer. However, in the presence of target, the competitor was displaced and an 
aptamer-target complex was formed. A signal-on detection scheme was used as shown in 
Figure 3.5. The fluorescence quenched in the double-stranded capture/aptamer complex 




All chemicals, enzymes, and kits used were purchased from commercially available 
sources. The oligodeoxynucleotides (ODNs) were obtained from the DNA/peptide Core 
facility at the University of Utah. Sanger sequencing of the plasmids was done at the DNA 




HPLC analyses of nucleoside reactions were done on a Beckman System Gold 
126NM solvent module attached to a Beckman 168NM diode array detector with a C-18 
nalytical reversed-phase column (5 µm, 250 × 4.6 mm) and Hypercarb column (5 µm, 150 
 × 4.6 mm). All solvents were HPLC-grade that were filtered and sonicated before use. 
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Figure 3.5. Strategy for aptamer-based optical detection by using signal-on detection 











   




Capture-SELEX Library, capture ODN, and primers design 
 The ODNs used for MS-SELEX are as follows: (1) A single-stranded random (N30) 
library (72-mer), 5’-Cy3-GGAGGCTCTCGGGACGACN30GTCGTCCCGATGCTGCA 
ATCGTAA-3’; (2) forward primer (FP, 18-mer), 5’-Cy3-GGAGGCTCTCGGGACGA 
C-3’; (3) reverse primer (RP, 24-mer) 5’-Btn-TTACGATTGCAGCATCGGGACGAC-3’; 
(4) biotinylated tetraethylene glycol (TEG) column immobilizing sequence (BtnDNA, 18-
mer), 5- GTC GTCCCGAGAGCCATA-btnTEG-3’.  
The ODNs used for YL-SELEX are as follows: (1) A single-stranded random (N30) 
library (94-mer), 5’-Cy3-CCTGCCACGCTCCGCAAGCTTN10CTGCAGCGATTCTTG 
ATGC N20TAAGCTTGGCACCCGCATCGT-3’; (2) forward primer (FP, 14-mer), 5’-
Cy3-CCTGCCACGCTCCG-3’; (3) reverse primer (RP, 21-mer) 5’-btn-ACGATGCGGG 




Preparation of buffer solutions 
The selection buffers or reaction buffers used for both the MS and YL-SELEX had 
different compositions and were prepared in nuclease-free water. The buffers used were 
(1) MS-SELEX buffer (100 mM NaCl, 10 mM MgCl2, 20 mM Tris, pH 7.4); (2) YL-
SELEX buffer (300 mM NaCl, 50 mM KCl, 10 mM MgCl2, 50 mM Tris, pH 7.4); (3) 
strand separation buffer (1 M NaCl, 20 mM Tris, pH 7.4). 
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Control experiments 
Four control experiments were conducted before starting the SELEX cycles to 
determine (a) the amount of streptavidin-agarose resin (1-3 mg biotinylated BSA/ mL of 
resin) for SELEX on micro bio-spin columns using gravity-flow method, (b) the loading 
capacity of the resin, (c) the hybridization efficiency of the library to BtnDNA, and (d) the 
binding efficiency of PCR amplified dsDNA on the resin and the yields of ssDNA eluted 
from column after strand separation were all determined.  
♦ (a) Amount of resin used for SELEX on the micro biospin columns: Micro bio-spin 
polypropylene chromatography columns (Bio-Rad) with a bed volume of 0.8 mL, bed 
height of 2 cm, and overall length of 3 cm were used for SELEX. The amount of 
streptavidin agarose resin (Thermo Scientific) used on these micro bio-spin 
chromatography columns for every SELEX round was determined so the flow rate was 
consistent using a gravity flow method. Different volumes of resin (50, 100, and 250 µL) 
were used to check the flow with the same amount of selection buffer (250 µL) through the 
column. 
♦ (b) Determination of maximum loading capacity of MS- and YL-BtnDNA on the resin: 
The streptavidin agarose resin with a binding capacity of 15-25 µg biotin/ mL of settled 
resin was used for SELEX experiments. The resin was stored in an azide solution as a 50% 
slurry mixture. Hence, for one mL of settled resin, it was reported that the loading capacity 
was ~ 0.06 - 0.12 µmol of biotin. We used 50 µL of settled resin (100 µL with slurry) and 
the calculated loading capacity of biotin to be 3 - 6 nmol. 
To precisely determine the maximum loading capacity of the BtnDNA, 50 µL of 
settled resin (minimum amount of resin) was loaded on two columns each with 6 nmol of 
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MS- and YL-BtnDNA, respectively. The column was equilibrated by washing with 3 X 
100µL of water, and then with 3 X 100 µL of MS- and YL-SELEX buffers, respectively. 
According to the protocol, the maximum loading capacity of resin, 6 nmol of MS- and YL- 
BtnDNA were incubated on two columns for 30 min at RT. The eluate was collected and 
BtnDNA was applied twice on the column, each for 5 min. The last eluate and five washes 
with buffer were collected separately and used to determine the amount of unbound (UB) 
BtnDNA for both the MS- and YL-ODNs by UV-measurements using a nanodrop 
spectrometer (Thermo Scientific). The difference between the total amount of BtnDNA 
loaded and the amount of BtnDNA collected from the eluate and combined washes gave 
the amount of BtnDNA loaded, and hence the maximum binding capacity of the resin. 
♦ (c) Hybridization efficiency of the library with capture strand: To determine the 
hybridization efficiency of MS- and YL-libraries on the capture strand or BtnDNA, 
different fractions of the library were added, as compared to 3 nmol of DNA, on 100µL 
resin. The different fractions were one-fourth, one-fifth, and one-sixth the concentration of 
MS- and YL-BtnDNA maximum loading capacity with 100 µL of resin. Therefore, for 3 
nmol MS- and YL-BtnDNA, 750, 600, and 500 pmol of the respective library was loaded 
and incubated for 1 h at RT. The eluate was collected separately to determine the amount 
of UB library. This was followed by 5 X 100 µL washes and 30 min incubation with only 
5 X 100 µL MS and YL 1X SELEX buffers to determine the background in each of these 
ratios. The background was the amount of library that eluted when incubated with 1X 
SELEX buffer. The fraction of the library that gave the least amount of background and at 
least 70% binding efficiency to BtnDNA was selected and used for all SELEX experiments 
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to minimize the background obtained in each cycle. All the measurements were done by 
fluorescence to measure the absorbance of the cy3-labeled library. 
♦ (d) Determination of binding efficiency of PCR amplified dsDNA on the resin and the 
yields of ssDNA eluted from the column after strand separation: The MS- or YL-ssDNA 
library was amplified by PCR with 5’-biotinylated reverse primers and purified by gel 
extraction to test the binding of the dsDNA on 200µL of resin. The column was equilibrated 
by washing with 5 X 200 µL water, and further with 5 X 200 µL strand separation (SS) 
buffer. 250 pmol of MS- or YL-dsDNA was applied to two columns, respectively, and 
incubated for 15 min at RT. The eluate was applied twice to the column for 5 min each and 
was collected to determine the amount of UB dsDNA by nanodrop. The resin was washed 
with 10 X 200 µL SS buffer and incubated with 200µL of 0.1 M NaOH for 10 min.  The 
eluate was collected and the step was repeated with 100µL of 0.1 M NaOH. The two above 
fractions from the column were collected, neutralized with 3M NaOAc, and concentrated 
using centrifugal filters. This determined the amount of ssDNA obtained from the column 
that was measured using fluorescence by nanodrop microarray that determines the 
concentration of the cy3-labeled library. 
Before starting the SELEX cycles, the targets were synthesized, HPLC purified, 
and characterized by electronic circular dichroism (ECD) spectroscopy that is discussed in 
the section below. A 4 mL stock solution of MS- or YL-BtnDNA on the resin was prepared 
beforehand for each SELEX for a target in order to use uniform concentration of BtnDNA 
and resin in each cycle. The procedure of binding BtnDNA to the streptavidin resin has 




   
Synthesis and preparation of target for SELEX 
Preparation of 8-oxo-dG and 8-oxo-G solutions: The targets used in this SELEX 
are shown in Figure 3.2. 8-Oxo-dG and 8-oxo-G were commercially available. A 100 µM 
stock solution of each target was made in MS- or YL-SELEX buffers. 
The procedure for the synthesis of dSp and Sp was conducted as follows: 39,40 dSp 
nucleosides were prepared in a large volume of 100 mL in 100 mM NaPi buffer at pH 8. 1 
mM dG was reacted with 500 µM methylene blue with a 350 nm light using a 300 W bulb 
suspended ~ 8 cm above the reaction for 1 h at RT. The photooxidant was removed by 
passing the mixture through a NAP-25 column (GE Healthcare) following the 
manufacturer’s protocol. Further, the unreacted dG was removed by passing the reaction 
mixture through a reversed-phase HPLC column. The mixture of dSp diastereomers was 
then collected from the void volume and the diastereomers were individually purified using 
a Hypercarb column. The method used for resolving the two diastereomers had line A as 
ddH2O with 0.1% acetic acid, and line B as methanol, running with flow rate of 1 mL/min 
at isocratic gradient of 0%B for 20 min followed by a linear increase in B to 75% over 25 
min. The reaction was monitored at 240 nm absorbance and the retention times for (-)-(R)-
dSp and (+)-(S)-dSp were 11 and 16 min, respectively. The yields of these reactions were 
approximately 15% and was obtained by Beer’s Law with the extinction coefficient of dSp 
at 245 nm. The HPLC traces and ECD spectra are consistent with previously published 
work on these diastereomers. Finally, a 100 µM stock solution was made for dSp 
nucleosides in MS-SELEX buffer. 
The (R)-Sp free-base was synthesized from purified (-)-(R)-dSp nucleoside.41, 42 
This was done by adding 40% HF in pyridine to an anhydrous pellet of dSp to give a final 
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concentration of 10 mg/mL. The sample was incubated at 45 °C for 30 min. Later, the HF 
was neutralized with 100 mg CaCO3, and the mixture was filtered. The pure Sp enantiomer 
was purified using a Hypercarb column with 70% yield. The enantiomer purity was 
confirmed by ECD spectroscopy. Since this enantiomer was HPLC purified with low 
yields, a stock solution of 100 µM was made in 1X MS buffer. 
 
 
PCR amplification of initial ssDNA library 
A 20 pmol (~1013 sequences) sample of both MS- and YL-ssDNA libraries were 
PCR amplified in a 10 mL PCR reaction using Taq DNA polymerase with ThermoPol 
Buffer (New England Biolabs) and 1 µM primers. PCR protocol for the MS-library 
consisted of 1 cycle of 95 °C, 2 min, 20 cycles of [95 °C, 15 sec; 60 °C, 30 sec; 72 °C, 45 
sec], and 1 cycle of 72 °C, 2 min. Each PCR cycle for the YL-library consisted of 1 cycle 
of 95 °C, 5 min, 15 cycles of [95 °C, 1 min; 62 °C, 1 min; 72 °C, 1 min], and 1 cycle of 72 
°C, 5 min. The PCR amplicons were extracted on 4% agarose gel followed by purification 
with a QIAEX II gel purification kit (QIAGEN). It is important to mention that this 
amplified library was used for all the five targets in SELEX.  Stochastic effects like loss of  
Sequemce variants due to random fluctuations are neglected as a consequence of having a 
large copy numbers of each sequence variant.  
 
General structure-switching or capture-SELEX protocol 
The general protocol for capture-SELEX is explained below, with each cycle 
consisting of 5 main steps (Figure 3.6). The number of cycles, target concentration, and 
counter SELEX done for each SELEX cycle vary with respect to the target used and will 
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be mentioned separately in the results and discussion section where each target is discussed 
separately. The general procedure involved mainly the following 5-steps for capture-
SELEX done on five targets. 
(1) Immobilization of the library on the resin: The first step involves the attachment 
of the BtnDNA to the library. As previously mentioned, a large amount of resin (4.5 mL) 
attached with BtnDNA was made in order to use the resin with the same loading capacity 
for all rounds of SELEX per target. To prepare such large amounts on the resin, 24nmol of 
BtnDNA was incubated on the resin for 24 h at RT using the rotor. The resin was 
centrifuged at low speed of 3000 rpm for 30 sec and the supernatant was collected and 
nanodrop was done to determine the amount of UB-BtnDNA. The resin was washed 
several times with 1X SELEX buffer and stored in the same buffer at 4 °C until further use. 
In each round, 100 pmol of ssDNA library was loaded on 250 µL BtnDNA resin in 
micro bio-spin chromatography columns. The ssDNA library was incubated for 1h at RT 
and the collected mixture was reapplied to the column twice for 15 min each time. The 
eluate was then collected to determine the amount of UB ssDNA in each cycle by nanodrop. 
The column was washed with 10 × 250 µL 1X SELEX buffer to remove unbound or loosely   
bound strands. The background was measured for each cycle by incubating SELEX buffer 
on the column for 30 min at RT.  
(2) Incubation of the target with the library: Incubation allows the target to interact 
with the library and strongly bound sequences lead to structure-switching. For all the 
SELEX cycles, the first round had 100 µM target in 250 µL SELEX buffer incubated on 
the resin for 30 min at RT. This step was repeated twice for 30 min at RT.  
(3) Elution of the aptamer from the column: Elute was then collected consisting of 
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Figure 3.6. The pictorial representation of each of the five steps of capture-SELEX. The 
brown circle represents streptavidin bead, the black pins are biotin, the ssDNA as cy3-




   
DNA-target complex using 3 × 250 µL of 100 µM target solution (collecting each 250 µL 
fraction separately). The eluted samples were then used as a template for PCR after 
concentrating to 100 µL by Amicon Ultra centrifugal filter (Millipore). The concentration 
of target used for further rounds to increase the stringency of SELEX is mentioned in the 
results and discussion section as these vary based on the target used. One important point 
to be made is that elution is strictly carried out using the gravity-flow method without 
disturbing or centrifuging the spin columns. 
(4) Amplification of the elute strands by PCR: The elute strands were amplified 
after every round with 25 cycles of 40 PCRs was set up with a negative and positive PCR 
in every cycle using 5’-biotinylated-RP and 5’-Cy-3-FP as controls. A negative PCR 
reaction consists of all components except the template, whereas a positive PCR reaction 
consists of the original ssDNA library. The protocol for both MS- and YL-PCR is 
mentioned in the section above in PCR amplification of the initial ssDNA library.  
For a 50 µL PCR reaction, 5 µL 10X buffer, 1 µL each of 50 µM FP and RP, 2 µL 
dNTPmix, 0.5 µL Taq polymerase, 2.5 µL elute containing ssDNA and 38 µL of nuclease 
free ddH2O was used. The dsDNA obtained from PCR was run on 4% agarose gel stained 
with ethidium bromide (EtBr) in 1X TAE buffer at 70 V for 1 h. The dsDNA bands were 
cut under UV light using a clean razor and the gel bands were dissolved at 55 °C in agarose 
dissolving buffer using a gel extraction kit (Zymogen). The amount of pure dsDNA was 
measured using nanodrop. 
 (5) Conversion of dsDNA to ssDNA: 200 µL of streptavidin resin was used on 
micro bio-spin columns at RT. The resin was washed with 5 × 200 µL water followed by 
5 × 200 µL SSB. In every round, ~250 pmol of dsDNA was loaded on the resin and 
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incubated for 15 min at RT. The mixture was reapplied to the column. The UB dsDNA was 
collected in eluate and measured by nanodrop. The column was washed with 5 × 200 µL 
of SSB followed by incubation of 200 µL 0.2 M NaOH on the resin at RT for 10 min.  A 
second fraction of 100µL NaOH was applied and eluate consisting of ssDNA was 
collected. The ssDNA obtained was neutralized by 3M NaOAc and was used for the next 
round as the initial library. 
 
 
Fluorescence detection  
The ssDNA library was labeled with Cy-3 at the 5’-terminus and the aptamer 
strands that eluted from each round were amplified using FP with 5’-Cy3. The amount of 
aptamer released during the target binding step was analyzed by fluorescence detection. 
The fluorescence measurement was performed on a nanodrop using microarray settings 
with excitation of Cy3 at 550 nm and emission at 570 nm. The concentration of DNA was 
determined with respect to fluorescence after every round. The targets did not influence 
the fluorescence readings. 
 
 
Cloning and sequencing 
The insert-DNA for cloning was prepared using aforementioned PCR conditions, 
except for the final extension step that was increased to 15 min at 72 °C to add an A-tail 
effectively for a T/A cloning system. The primers used for amplification in this case did 
not have any modifications at the 5’ or 3’-end. The PCR amplicons were purified as 
previously mentioned and were directly incorporated into the plasmid vector (pCR 4-
TOPO) using TOPO TA cloning kit (Invitrogen) following the manufacturers protocol. 
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The vector and its linearized form are shown in Figure 3.7. The plasmids were then 
transformed into one shot TOP10 competent cells (Invitrogen), and the positive clones 
containing recombinant plasmid were identified by blue/white screening. Each colony was 
picked and replated for growth on Petri dishes containing LB Agar (MO-BIO) and 
ampicillin (Sigma). Finally, the individually grown colonies were picked and re-grown in 
3 mL of Luria Broth (LB media). This procedure has been represented in Figure 3.8 and is 
followed for all targets. The cell pellets were obtained and each individual plasmid was 
extracted using a PureLink Quick Plasmid Miniprep Kit (Invitrogen). Positive clones were 
confirmed by PCR and Sanger sequencing was performed at the DNA Sequencing facility 
at University of Utah. The analysis of each electropherogram files (AB1 files) and 
verification of each error was completed using Chromas Lite. Multiple sequence alignment 




Sensor selection for measurement of binding affinities 
            The  sensors  were designed after truncating most bases in the primer regions  
and  the  secondary  structures  were  determined  using  Quikfold.    A  bischromophoric  
approach was applied where the sensor was labeled with carboxyfluorescein (5-FAM).  It 
folded into a 7-8 base pair (bp) stem region that competes with 13- or 14-mer quencher or
capture  strand  that  acts  as  a  complimentary capture strand with 3’-dabcyl modification. 
Each sensor with a specific 13- and 14-mer was designed to perform fluorescence studies. 
All fluorescence measurements were carried out in SELEX buffer. Each sensor was 
separately incubated with the 13- or 14-mer quencher strands, annealed at 95 °C for 10 min 
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Figure 3.7. The pCR-4 TOPO TA vector and the linearized plasmid used for cloning. The 





























   
and flash cooled to 4 °C for 10 min and then at RT for 30 min. Each sensor had a constant 
concentration of 5 nM, whereas the quencher strands ranged from 0-100 nM. The 
fluorescence was measured on a 96-well black plate (Costar) at excitation wavelength for 
5-FAM at 490 nm and emission at 520 nm. The experiments were done in three trials and 
relative fluorescence units (RFU) were plotted against concentration of quencher strands. 
This plot determines the Kdeff1 of the quencher by Equation (1) in Scheme 3.1. For each 
target, at least four different sensor and quencher sequence combinations were used and 
only one or two of these showed decrease in fluorescence with increase in quencher 
concentration upon hybridization. The sensor and quenchers ratio that showed 60% 
quenching was further used for target binding studies to determine the binding affinity 
(Kdeff2) of the target measured by Equation (2) in Scheme 3.1. The sensor-quencher strand 
ratio selected was incubated with target concentrations ranging from 2 nM - 500 µM. The 
KD,aptamer was determined by Equation (3) in Scheme 3.1. The details of the sensor and 
capture or quencher sequences tested for every target and the aptamer with their binding 
affinities are mentioned in the results and discussion. 
 
Results and discussion 
Control experiments results 
The amount of resin used on the column was determined for every round of SELEX 
based on the consistent flow-rate for 250 µL of buffer. Since SELEX was performed on 
micro bio-spin chromatography columns using a gravity-flow method, a consistent flow 
through the column was necessary to carry out every round of SELEX. Henceforth, 250 
µL of resin was used for every round of SELEX. The maximum loading capacity of the 
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Scheme 3.1. Equations for two different affinities of the capture strand (Kdeff1) and of the 
















   
biotinylated capture strand on 50 µL settled streptavidin resin was determined. It was found 
that the maximum loading capacity of the resin was 3 nmol of capture strand. 
The hybridization efficiency of the library with the capture strand was determined 
so the least amount of background was observed. This was important for SELEX to be 
performed as this would decrease the background loss in SELEX. The least amount of 
background was observed with one-fifth concentration of the library (600 pmol) as 
compared to the capture strand. The percentage of library that was hybridized and loaded 
on the column was 80% of the total amount loaded. 
The conversion of dsDNA to ssDNA for both the MS- and YL-libraries was 
determined by loading the dsDNA on streptavidin resin and capturing the biotinylated 
antisense strand. The amount of ssDNA obtained was measured in concentration by 
fluorescence as the sense strand was cy3-labeled. For 250 pmol of dsDNA loaded, the 
amount of ssDNA obtained was 110 pmol. 
 
 
dSp and Sp HPLC and ECD data  
The 2’deoxyspiroiminodihydantoin diastereomers, (-)-(R)-dSp and (+)-(S)-dSp 
were synthesized and HPLC-purified as mentioned in the experimental section. The HPLC 
traces of both 2’deoxy-spiroiminohydantoin diastereomers purified on a Hypercarb column 
are shown in Figure 3.9. To verify the purity of the diastereomers, we performed electronic 
circular dichroism of the two diastereomerically-pure dSp samples, (-)-(R)-dSp and (+)-
(S)-dSp (Figure 3.10). The high performance liquid chromatography trace determined by 
recording at 280 nm and electronic circular dichroism spectrum for the enantiomer (R)-Sp 
are shown in Figure 3.11.  
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Figure 3.9. HPLC trace for the purification of the dSp diastereomers on a Hypercarb 
column. Peaks 1 and 2 were purified separately and indicate (-)-(R)-dSp and (+)-(S)-dSp, 
the two diastereomers of dSp nucleoside. The inset shows the UV spectra for both 
nucleosides at recorded over 200-300 nm. The HPLC trace was determined by recording 
























Figure 3.10. ECD spectra of both the purified diastereomers of dSp. The above ECD 









































CD Spectrum of  (+)-(S)-dSp
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Figure 3.11. HPLC purification spectra on Hypercarb column and ECD spectrum for the 
purified (R)-Sp enantiomer. The inset in the hplc trace shows the UV spectra for the 
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Capture-SELEX for lesions 8-oxo-G and 8-oxo-dG 
Both MS- and YL-SELEX aptamer selections were done for 8-oxo-G, a common 
biomarker of oxidative stress.43 100 pmol of starting library was loaded on the column for 
each cycle. The concentration of target ranged from 1-100 µM over 13 cycles. Negative 
selection was done in round 7 with 100 µM dG, dA, dT, dC, and uric acid (UA). UA is a 
metabolic breakdown product of purine nucleotides. MS-SELEX was carried out on 1-100 
µM 8-oxo-dG target concentration over 13 cycles and negative selection was done 
similarly as outlined above. The details of target concentration for every round and the 
negative selections are mentioned in Table 3.1 for 8-oxo-G and 8-oxo-dG.  
The elution profiles for the background and target in each round of SELEX are 
shown in Figures 3.12 and 3.13 for 8-oxo-G MS- and YL-SELEX, whereas Figure 3.14 
shows an elution profile for 8-oxo-dG MS-SELEX. The amount of ssDNA eluted in pmol 
was measured by the Cy-3 fluorescence after each round. The elution profiles help monitor 
the progress of SELEX. In the initial rounds, when only small amount of specifically target-
bound ODNs are present in the solution, the ratio of background to target elution equals 
one. 
 In later rounds, as successful selection of the aptamers proceeds, the amount of 
target binders increased and hence the ratio elevates. This was followed by amplifying the 
binders using PCR with the number of cycles changing depending on the elution profiles 
in each cycle. 4% Agarose test gels were run on amplicons after every round and scanned 
on a Typhoon imager are shown in Figure 3.15 (a) and (b) for 8-oxo-G and 8-oxo-dG MS-
SELEX and Figure 3.16 (a) and (b) for 8-oxo-G YL-SELEX. After transformation of 
cloned plasmid, 50 colonies were picked from each SELEX and the sequences obtained  
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Table 3.1. The details for the number of rounds performed during SELEX and the 












(MS and YL-SELEX) 
8-oxo-dG  concentration 
1 100 µM 100 µM 
2 100 µM 100 µM 
3 100 µM 100 µM 
4 100 µM 100 µM 
5 100 µM 100 µM 
6 100 µM 100 µM 
7 100 µM (dA, dT, dG, dC, 
UA) counter selection 
100 µM target 
100 µM (dA, dT, dG, dC, 
UA) counter selection 
100 µM target 
8 50 µM 50 µM 
9 50 µM 50 µM 
10 25 µM 25 µM 
11 25 µM 25 µM 
12 10 µM 10 µM 
13 1 µM 1 µM 
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Figure 3.12. Elution profile for the background and aptamer strands for every SELEX  





























Elution profile for 8-oxo-G with MS-SELEX
Background in picomoles Elution of aptamer in picomoles
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Figure 3.13. Elution profiles for background and aptamer strands eluted in each SELEX 





























Elution profile for 8-oxo-G with YL-SELEX
Background in picomoles Elution of aptamer in picomoles
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Figure 3.14. Elution profiles of 8-oxo-dG SELEX for every round representing the elution 





























Elution profile for 8-oxo-dG with MS-SELEX
Background in picomoles Elution of aptamer in picomoles
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Figure 3.15. 4% Agarose test gels of MS-SELEX for 8-oxo-G and 8-oxo-dG. (a) First 6 
rounds. Lanes 1 and 2 represent the forward primer, and ssDNA MS-library. In rounds 
(Rd) 1 and 2, lanes 3, 4, and 5 represent negative, positive, and elute PCR for that round. 
However, in rounds 3-6, lanes 3, 4, and 5 represent negative, positive, and elute PCR for 
that round for 8-oxo-G (labeled as OG above. Lanes 6, 7, and 8 represent negative, positive, 
and elute PCR for that round for 8-oxo-dG (labeled as dOG). (b) 7-13 rounds. Lane 1 
represents ssDNA MS-library. Lanes 2, 3, and 4 as negative, positive, and elute PCR for 
that round for 8-oxo-G.Whereas, lanes 5, 6, and 7 represent negative, positive, and elute 
PCR for that round for 8-oxo-dG.  
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Figure 3.16. 4% Agarose test gels of 8-oxo-G YL-SELEX. (a) For the first six rounds. (b) 
for the rounds 7-13. Lane 2 represents ssDNA YL-library. Lanes 3, 4, and 5 represent 
























   
are shown for 8-oxo-G and 8-oxo-dG with MS-SELEX in Table 3.2 and Table 3.3. The 
sequences obtained for 8-oxo-G for YL-SELEX are shown in Table 3.4. The sequences for 
8-oxo-G YL-SELEX had several deletions and mutations in most regions and were not 
further studied for binding. Each sequence from MS-SELEX was further truncated in the 




Capture-SELEX for diastereomeric dSp and enantiomeric (R)-Sp lesions 
The selection of aptamers for the diastereomers of dSp was done using MS-SELEX 
library. Aptamer selection for (R)-Sp, a product of BER removed by hNEIL1 and hNEIL3 
DNA glycosylases,44 was done in 8 rounds of selection using the MS-library. The choice 
of only (R)-Sp for SELEX was based on high HPLC purification yields of this enantiomer 
as compared to its counterpart. Eight rounds of SELEX were performed individually for 
each target. Every round was initiated by loading 100 pmol of starting library on the column 
round of 8-oxo-G using MS-SELEX. 
The concentration of target for dSp and Sp varied from 1-100 µM in each round 
and are shown in Tables 3.5 and 3.6, respectively. Counter SELEX was done in round 2 
with 100 µM dG, dA, dT, dC, and UA. Another counter SELEX cycle for dSp nucleosides 
was done in round 6 with 10 µM 8-oxoG, 8-oxo-dG and the other diastereomer of dSp. The 
counter selection was done rounds apart to enrich the pool in consecutive cycles, to prevent 
the loss of strong affinity aptamers. The elution profiles for the background and target after 
every round of SELEX are shown in Figures 3.17, 3.18, and 3.19 for (-)-(R)-dSp, (+)-(S)- 
dSp, (R)-Sp, respectively. 
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Table 3.2. The insert sequences obtained (labeled M) from cloning for 8-oxo-G by MS-
SELEX. The N30 random regions are only indicated here. Number of sequences represent 
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Table 3.3. The insert sequences obtained (labeled dMS) from cloning for 8-oxo-dG by 
MS-SELEX. The N30 random regions are only indicated here. Number of sequences 
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Table 3.4. The sequences obtained (labeled Y) after 8-oxo-G YL-SELEX. The sequences 
obtained from this type of library were less in number and often involved deletions in 
primer, random, and capture strand regions. The blue regions indicate primer sites, whereas 









































ATTTGGCATATTCCCTGAACTAAGCTTGGCACCCGCATCGT   
 
CCTGCCACGCTCCGCAAGGCTTTAGCCACTGGCTGCAGTGATCCTTGATCG 
ATTTGGCATATTCCCTGAACTAA GCT TGG CAC CCG CAT CGT 
 
CCTGCCACGCTCCGCAAGGCTTGCACGAGGCGCTGCAGTGATTCTTGATCG 
CAATTCTGGCCAACGACTAG TAAGCTTGGCACCCGCATCGT   
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1 100 µM 100 µM 
2 100 µM (dA, dT, dG, dC, 
UA) counter selection 
100 µM target 
100 µM (dA, dT, dG, dC, 
UA) counter selection 
100 µM target 
3 50 µM 50 µM 
4 25 µM 25 µM 
5 25 µM target 25 µM target 
6 10 µM (8-oxo-G, 8-oxo-dG,  
(+)-(S)-dSp) counter selection 
10 µM target 
10 µM (8-oxo-G, 8-oxo-dG,  
(-)-(R)-dSp) counter selection 
10 µM target 
7 10 µM  10 µM 
8 1 µM 1 µM 
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1 100 µM 
2 50 µM (dA, dT, dG, dC, UA) 
counter selection 
50 µM target 
3 50 µM 
4 25 µM 
5 25 µM  
6 10 µM (8-oxo-G, 8-oxo-dG, (-)-
(R)-dSp, (+)-(S)-dSp) counter 
selection 
10 µM target 
7 10 µM  
8 1 µM 
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Elution profile for (-)-(R)-dSp with MS-SELEX
Background in picomoles Elution of aptamer in picomoles
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Elution profile for (+)-(S)-dSp with MS-SELEX
Background in picomoles Elution of aptamer in picomoles
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Elution profile for (R)-Sp with MS-SELEX 
Background in picomoles Elution of aptamer in picomoles
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The concentration of eluted ssDNAs was measured by the Cy-3 fluorescence. After 
each round of selection and amplification, agarose test gels were scanned on an imager for 
fluorescence as shown in the Figures 3.20 (a) and (b) for (-)-(R)-dSp, (+)-(S)-dSp and 
Figures 3.21 (a) and (b) for (R)-Sp, respectively. Upon transformation of cloned plasmid, 
50 colonies were picked and sequenced. The insert DNAs are listed in Tables 3.7, 3.8, and 
3.9 for (-)-(R)-dSp, (+)-(S)-dSp, and (R)-Sp, respectively.  
The post-SELEX modifications of selected sequences were done by truncating 
primer regions and designing sensors for studying binding affinities of the sensors to the 
respective targets. At least four sequences, obtained from cloned plasmid, PCR amplified, 
and converted to ssDNA where tested with the respective target for their elution and the 
sequences that showed highest elution were further used for designing sensors and testing 




Binding studies or KD measurements 
Different sensors were designed for every SELEX round and selected based on 
predicted M-fold structures. There were mainly four types of structures obtained in all 
SELEXs for all targets: three-way junctions (3WJ), hairpin loops, and stem loops with one 
or more symmetric internal loops. The M-fold structures are shown in Figure 3.22. The 
sensor and capture sequences were designed based on using a 7-8 bp stem loop for sensor 
and 13- and 14-mer capture or competitor strands complementary to the sensor region are 
shown in Tables 3.10, 3.11, 3.12, 3.13, and 3.14. for 8-oxo-G, 8-oxo-dG, (-)-(R)-dSp, (+)-
(S)-dSp, and (R)-Sp, respectively. The number in brackets at the end of every sequence in 
table indicates the predicated melting temperature of the strands using Quikfold and oligo 
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Figure 3.20. 4% Agarose gels of MS-SELEX for dSp nucleosides. (a) The first four rounds 
of SELEX. (b) rounds 5-8 of MS-SELEX. Lanes 1 and 2 represent forward primer, and 
ssDNA library. Lanes 3, 4, and 5 refer to negative, positive PCR, and elute PCR, 
respectively for that cycle of (-)-(R)-dSp. Lanes 6, 7, and 8 represent negative, positive 








































Figure 3.21. 4% Agarose test gels of MS-SELEX for (R)-Sp. (a) The first four rounds of 
SELEX. (b) Rounds 6-9 of SELEX. Lanes 1 and 2 represent forward primer, and ssDNA 
library. Lanes 3, 4, and 5 refer to negative, positive PCR, and elute PCR, respectively, for 





































   
Table 3.7. Insert DNA sequences (labeled dSpA) for (-)-(R)-dSp MS-SELEX obtained 
after cloning. The random N30 regions of the library are shown here and the number of 









































































AGGAGAGTCGTTAGGTACTAAGACCGAAAA   
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Table 3.8. Insert DNA sequences (labeled dSpB) for (-)-(S)-dSp SELEX obtained after 
cloning. The random N30 regions of the library are shown here and the number of sequences 







































































   
Table 3.9. Insert DNA sequences (labeled SpA) for (R)-Sp MS-SELEX obtained after 
cloning. The random N30 regions of the library are shown here and the number of sequences 






































































































































Figure 3.22. The four different forms of M-fold structures obtained from the truncated 











   
Table 3.10. The sequences of the selected 8-oxo-G sensors, and 13 or 14-mer quenchers 









OG sensors (5’-FAM) and quenchers (3’-Dab) 







































13mer:    
5’-FAM-GACGACAGCCAGTTGTTAGAATGGTTGAACCCGTGA (54) 
 
5’-AACTGGCTCTCGTC /3’Dab (58) 




5’-AGTCGTCCCGAGAG /3’Dab (59) 




5’-GGTCGTCCCGAGAG /3’Dab (60) 









5’-CGTCGTCCCGAGAG /3’Dab (60) 















5’-TGTCGTCCGAAGC /3’Dab (58) 
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Table 3.11. The sequences of the selected 8-oxo-dG sensors, and 13 or 14-mer quenchers 






dOG sensors (5’-FAM) and quenchers (3’-Dab) 

















































5’-TAGTCGTCCGAGAG /3’Dab (53) 




5’-CCCGTCGTCCCGAG /3’Dab (64) 



















5’-CCCGTCGTCCCGAG /3’Dab (64) 














5’-ATGTCGTCCCGAGA /3’Dab (59) 
5’-TGTCGTCCCGAGA /3’Dab (58) 
129 
   
Table 3.12. The sequences of the selected (-)-(R)-dSp sensors, and 13 or 14-mer quenchers 
















(R)-(-)-dSp sensors (5’-FAM) and quenchers (3’-Dab) 



































5’-AAGGCCGTCGTCCC -3’Dab (64) 




5’-TCTCCGGTCGTCCC -3’Dab (62) 
5’-CTCCGGTCGTCCC -3’Dab (60) 
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Table 3.13. The sequences of the selected (+)-(S)-dSp sensors, and 13 or 14-mer quenchers 
















(S)-(-)-dSp sensors (5’-FAM) and quenchers (3’-Dab) 











































   
Table 3.14. The sequences of the selected (R)-Sp sensors, and 13 or 14-mer quenchers 

















(R)-Sp sensor (5’-FAM) and quenchers (3’-Dab) 













































   
analyzer with the same ionic strength as in the experimental studies.  
A fixed concentration of 5 nM of sensor strand showed substantial quenching of 
fluorescence upon hybridization. Various concentrations 0-500 nM of capture strand where 
selected. The sensor-capture strand fixed ratio that showed more than 60% quenching was 
selected to determine Kdeff2 with target to see an increase in fluorescence signal upon 
addition of higher concentration of target until saturation occurs. The ratio of both 
Kdeff1/Kdeff2 was used to determine the Kd for the aptamer. Two dOG sensors (Figure 3.23), 
two OG sensors (Figure 3.24), two (-)-(R)-dSp sensors (Figure 3.25), one (+)-(S)-dSp 
(Figure 3.26), and two (-)-(R)-Sp sensors (Figure 3.27) showed a significant change in 
fluorescence upon hybridization with 13- or 14-mers. All these figures show the two graphs 
obtained each for 13 and 14-mer capture strand along with the sequences and 
M-fold structures for each sensors and the calculated Kdeff1 for each 13 and 14-mers. The 
Kdeff1 was calculated by Equation (1) from Scheme 3.1 by determining the amount of free 
capture, free aptamer, and the amount of aptamer-capture dsDNA at the half maximum 
value according to the plots obtained. 
Among the dOG sensors, the lowest Kdeff1 of 1.5 nM was obtained for 13-mer with 
dOG_7, both 13- and 14-mer for sensor dOG_10. Among the OG sensors, the Kdeff1 were 
around 2-3 nM for all combinations. All (-)-(R)-dSp sensors had much higher Kdeff1, the 
highest one being ~68 nM for 13-mer with (-)-(R)-dSp8_8. Also, for the only sensor (+)(S)-
dSp7_7, the Kdeff1 was 75 nM for both capture strands. For all (-)-(R)-Sp capture strands 
the Kdeff1 ranged from 25-50 nM. 
          Once the Kdeff1 was calculated, the ratio of the capture strand with higher than 60%  
quenching was selected to titrate various concentrations of target and determine the Kdeff2.  
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Figure 3.24. OG sensors with respective 13-and 14-mer capture strands and their 
hybridization fluorescence quenching plots and their Kdeff1. 
 
135 






Figure 3.25. (-)-(R)-dSp sensors with respective 13-and 14-mer capture strands and their 













Figure 3.26. (+)-(S)-dSp sensors with respective 13-and 14-mer capture strands and their 















Figure 3.27. (-)-(R)-Sp sensors with respective 13-and 14-mer capture strands and their 





   
The target was serial diluted from 500 µM to 2 nM and added to constant sensor and capture 
strand concentration. The fluorescence increases with higher concentration of target and 
eventually results in saturation. The Kdeff2 obtained for all targets dOG (Figure 3.28), OG 
(Figure 3.29), (-)-(R)-dSp (Figure 3.30), (+)-(S)-dSp (Figure 3.31), and (-)-(R)-Sp (Figure 
3.32) are shown. The Kdeff2 was calculated with the Equation (2) in Scheme 3.1 and the 
concentration of free target, free competitor, aptamer-target complex, and aptamer-
competitor were obtained from the graph. The Kd,aptamer is then calculated from both the 
Kdeff1 and Kdeff2 obtained. Among the several sensors, the one obtained with lowest binding 
affinity was determined as a high affinity aptamer for the target. 
 
Conclusion 
We performed MS-SELEX on various targets that are products of guanine 
oxidation. The nucleosides are the products of nucleotide excision repair (NER), whereas 
the nucleobases are products of base excision repair (BER) pathway. We were successfully 
able to carry out the SELEX on all the targets separately in 8-13 rounds. The sequences 
were obtained had great diversity with respect to the target. None of the sequences matched 
between two targets and is a good indication that these sequences are not background. 
The 8-oxo-G free base had both OG10 and OGMS1 DNA aptamers with Kd 5 nM. 
The very low Kd obtained can be explained by the high stacking interaction of the OG free 
base with the aptamers. The structure of both the OG and (-)-(R)-Sp aptamers was similar 
and had a hairpin structure with internal loop present. The only other free base for which 
the SELEX was done, (-)-(R)-Sp8_8 aptamer, had a Kd of 10nM. The free base DNA 
aptamer in general showed lower Kd than the nucleoside counterparts. (-)-(R)-dSp5_8, DNA 
aptamer for the diastereomer of dSp had Kd of 14nM, whereas for the other diastereomer (+)- 
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Figure 3.28. The dOG_7 sensor with increased concentration of the target and the 
















Figure 3.29. The OG_10 sensor with increased concentration of the target and the 
















Figure 3.30. (-)-(R)-dSp_5_19 sensor and 14-mer capture strand with increased 

















Figure 3.31. (+)-(S)-dSp7_7 sensor with increased concentration of the target and the 
















Figure 3.32. (-)-(R)-Sp8_8 sensor with increased concentration of the target and the 











   
(S)-dSp, the Kd of the DNA aptamer (+)-(S)-dSp7_7 was 95 nM. These aptamers are 
surprisingly similar in their secondary structure to the OG, and (-)(-)-(R)-dSp5_8, a DNA 
aptamer for the diastereomer of dSp with Kd of 14nM. The (R)-Sp base aptamer, however, 
has a hairpin with internal loops. This is the only other case where the aptamers are reported 
for diastereomers apart from the (R) and (S)-ibuprofen (Kd = 4µM) and (R)-thalidomide 
(Kd = 1µM). We were able to obtain Kd in lower nM range for these diastereomers. 
The only DNA aptamers that had Kd in micromolar range was for dOG target. The 
8-oxo-dG aptamers, dOG_7 and dOG_10 had Kd as 20 µM. This was unexpectedly higher 
than the previously reported 8-oxo-dG RNA aptamer that had Kd of 270 nM and a DNA 
aptamer with Kd 100 nM. 45, 46 However, one needs to mention that there might be better 
aptamers among the other sequences that have not been tested in the binding studies. 
The further aim with respect to this project in our lab will be explained briefly in 
Chapter 4. The short-term goal is to test these aptamers for their specificity and affinity in 
vitro and further test them in cellular samples and be able to measure the oxidative stress 
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The aim of this dissertation research is to aid in developing a new method for 
detection of damaged bases that is sensitive at very low concentrations. After several 
attempts, I have been able to develop an approach to select aptamers effectively against 
these damaged bases. The aptamers selected have also been truncated to design sensors 
and determine their binding affinity that are mostly in the low nM range. The long-term 
goal of this project is to detect damages in cellular samples effectively. There are several 
ways one can test the aptamer developed for the target before proceeding to in vitro studies.  
Aptamers as molecular recognition elements have found a wide variety of 
applications as biosensors. Split aptamers that comprise two nucleic acid strands, designed 
by systematic truncation of aptamer stem regions, can be applied to test these aptamers. 
These truncated strands assemble selectively in the presence of the desired target. The 
assembly of these DNA strands can be translated into a ligation reaction based on the split 
aptamer proximity ligation technology (StAPL) developed recently by the Heemstra lab 
(Figure 4.1).1 This has been applied to three-way junction aptamers for cocaine detection. 
They have also recently developed a general approach applied to other architectures of 
























Figure 4.1. Cocaine-dependent split aptamer ligation using strain-promoted azide-alkyne 



























Figure 4.2. Possible sites of splitting aptamers based on their architecture (above). The 
fluorescence and quenching strategy used as a general approach to split aptamer dependent 






However, the three-way junctions are more “privileged structures” to study small 
molecule detection using this technology. Aptamers developed as sensors for some of the 
targets in Chapter 3 show three-way junction architecture, and this technology can be 
applied to the study of these aptamers. Besides, one can also test other aptamer 
architectures, like hairpins, obtained in the study by selectively truncating the stem regions 
and optimizing the buffer conditions. Diastereomeric lesions can also be studied by adding 
a diastereomeric excess of one target and using this technology. By using the split aptamer 
technology, one can confirm that the selected truncated aptamer assembles selectively in 
the presence of the desired diastereomeric target. 
Using the split aptamer technology sheds some light on the structural aspect of 
aptamer binding to a small molecule where X-ray and NMR data are unavailable. However, 
chemical modification of the aptamers provides inadequate information about the part of 
aptamer regions that are in close proximity or in contact with the target. To evaluate the 
significance of specific base compositions on aptamer binding, exploring the sequence 
space of the aptamer by mutation might provide some insight into the target binding 
topology of the aptamer. Research has shown that mutations play a significant role in either 
completely disrupting the secondary structure or forming a new secondary structure or a 
new recognition loop in the aptamer.3 Attempts have been made in the past to evolve 
aptamers with altered specificity. One of the examples for this is the arginine aptamer 
obtained after 30% mutagenesis of the citrulline aptamer.4 Mutation of a few bases in the 
aptamer changes its secondary structure and results in small changes in target specificity. 
This might be a very useful approach to evolve aptamers specifically for various other 
DNA oxidation lesions being discovered by the Burrows group and other laboratories. 
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Single, double, or triple mutations can be created by using DNA microarrays to test base 
composition on aptamer binding and identify the possible structural motif in binding. 
Single mutations from G to T at position 1 (increase affinity), T to A at position 17 (much 
weaker affinity), or C to T at position 19 (similar affinity) at different positions have shown 
a significant affect in binding affinity of the original IgE aptamer (Figure 4.3).5 The binding 
affinity (KD) was determined using fluorescence anisotropy. The original aptamer had KD 
of 15 nM, whereas G to T mutation had higher binding affinity KD of 7 nM, C to T mutation 
had similar KD of 19 nM as original aptamer, whereas, the binding affinity decreased 
drastically for T to A mutation with KD of 450 nM. Double and triple mutation 
combinations at certain positions (11, 18, 19, 22, 23 and 24) have significant binding signal 
for IgE aptamer.5 
In vitro studies can be performed on cell lysates that are treated with ROS to 
generate oxidative stress resulting in a specific type of lesions based on optimized 
conditions (buffer, pH, and the type of oxidant used) and treated with proteases and 
nucleases to detect a specific lesion using any of the abovementioned biosensor methods 



















Figure 4.3. Predicted secondary structure of IgE-binding aptamer. The effect of single 
mutation on the binding of the aptamer to the target. This figure has been adapted from 
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